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ABSTRACT
Threonine synthase catalyses the conversion of (2S)-0-phosphohomoserine to 
(2S,3f?)-threonine with the elimination of phosphate. A novel and efficient 
synthesis of (2S)-0-phosphohomoserine has been developed starting from (2S)- 
aspartic acid. Using this methodology the singly labelled isotopomers (2S,3S)- 
[3 -^H i]-, (2S ,3H )-[3-^H i]-, and (2S)-[2-^Hi]-0-phosphohomoserine have also 
been synthesised from labelled (2S)-aspartic acid and used to probe the 
mechanism of the enzyme. Measurement of the kinetic deuterium isotope effects 
for the labelled substrates showed that both the C“-H and CP-H proton removal 
steps in E. co//threonine synthase display primary deuterium isotope effects, and 
that cleavage of the C-3-(pro-S)-H bond is at least partially rate limiting. This 
confirms data already available for the yeast enzyme, which indicated that the 3- 
pro-S proton is removed in the course of the reaction. The kinetic isotope effect for 
the removal of the 3-pro-S proton indicates a high forward commitment for the 
elimination of phosphate.
Threonine synthase from E. co//was also shown to be activated in the presence of 
S-adenosyl methionine. This activation has been documented for the plant 
enzyme, but this is the first time such an activation has been seen for the bacterial 
enzyme.
Threonine synthase for the study was partially purified from E. co// K12 Tir8, using 
novel methodology.
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INTRODUCTION
1.0 Pyridoxal 5 '-Phosphate Dependent Enzymes.
Several hundred enzymes use pyridoxal 5 ’-phosphate (PLP) (1) as a cofactor. 
These include the transaminases, the decarboxylases and the racemases among 
others.
OH HO
OH
OH
CH
Paul Gyorgy first discovered the nutritional factor vitamin Bq (pyridoxol) (2), of 
which PLP is a metabolite, in 1934.“* When purified preparations of thiamine and 
riboflavin became available in the early 1930's it became apparent that another 
heat stable vitamin, later called vitamin Be, was required to prevent the 
development of a florid dermatitis (acrodynia) in rats. This compound was isolated 
independently by five laboratories in 1938, and its structure and synthesis were 
reported in 1939 when it was named pyridoxine.^ Snell discovered that vitamin Be 
occurs in multiple free forms, and by studying non-enzymic transaminations 
between pyridoxal and amino acids he provided the first clues to the function of the 
vitamin.^
PLP was eventually recognised as probably nature's most versatile coenzyme, 
playing a crucial role in a number of important processes. PLP is the required 
cofactor for enzymes integral to amino acid metabolism and in connecting the 
carbon and nitrogen cycles. The coenzyme is also involved in the formation of 
biogenic amines and in providing entry into the “one-carbon pool". The fact that
PLP dependent enzymes occur in four of the six EC classes reflects its versatility.^ 
Experimental Be deficiency in animals results in vitamin Be pellagra, characterized 
by loss of hair, edema and red, scaly skin. Deficiency inhibits the degradation of 
(2S)-tryptophan, and excretion of xantherenic acid (a product of tryptophan 
degradation) is used as an index of vitamin Be deficiency.
S tructure and Mechanism of PLP Enzymes.
The general theory of the PLP mediated amino acid reactions was developed 
independently by Braunstein and Snell in 1953-54.®-® PLP binds to these 
apoenzymes through the 4-aldehyde group to yield the holoenzyme (3). In all 
known PLP enzymes studied to date this Schiff's base - the so-called internal 
aldimine - is derived from the e-amino group of an active-site lysine residue.
LysI
nT c Hs
H
(3)
oTransaldimination -q
HR - ^ C O ;
V h6
|| ^
Ife CHa
H
(4)
Scheme 1.01 : PLP and substrate at the enzyme active site.
Upon the formation of the holoenzyme, the amino acid substrate can bind to give 
the Michaelis complex. The internal aldimine can undergo a transaldimination 
(sometimes called transimination) reaction with the bound amino acid, which now
leads to the formation of a Schiff’s base substrate aldimine or external aldimine 
complex (4) (Scheme 1.01). The structure of the aldimine (4) was first put forward 
by Braunstein and Snell as a possible solution to the mechanistic problem of how 
to effect C«-H bond cleavage in generating a stabilised intermediate such that the 
resulting carbanion was not too basic to be kinetically competent. Thus, it was 
suggested that C^-H bond cleavage would be stereoelectronically assisted by the 
geometry in the external aldimine, as the charge on the pyridinium nitrogen could 
be transmitted via the conjugated 7i-system to the substrate a-carbon atom. The 
lability of the bonds to the C“ -atom is therefore increased due to the electron 
withdrawal from C^.
According to the hypothesis of Dunathan, these cleavages are stereoelectronically 
assisted by disposing the bond to be broken perpendicular to the plane of the 
pyridinium ring, thereby maximising orbital overlap between the developing 
negative charge and the conjugated, electron deficient Ti-system, Scheme 1.02.^-® 
Indeed, quantum mechanical calculations have shown that the strength of a a  bond 
between C® of the Schiff's base and the electrofuge is least when the bond lies 
orthogonal to the pyridinium ring.®
Hjt" ■
N e  CH3 
H
•OoC>.
2-O3PO
Y
N HI
O
N CH3 
H
O3PO
H q C u  (Po~H
H o C ^  ( > 0 - H
H
O3PO
Schem e 1.02: Preferential cleavage of the bond orthogonal to the plane of the 
pyridinium ring, as predicted by the Dunathan hypothesis. This example shows 
C^-H cleavage, but and bond cleavage (i.e. decarboxylation
and retro-aldol reaction respectively) can also occur.
Experimental support for the idea that the lability of the C“ -R bond is enhanced 
when it is held orthogonal to the 7c-system has been provided by A b b o t I n  a 
complex between cobalt (III) and PLP-glycine Schiff's base (5), the two 
C(^-hydrogens are held in distinct conformations relative to the 7c>system, and 
apparently exchange at different rates, as measured by ^H-NMR spectroscopy.
HO
N é CH;
The structure of the external aldimine (4) at the active site has yet to be fully 
established in most cases, but a trans configuration at the imine double bond 
would be sterically favourable, avoiding the interactions that would occur if the C-5’ 
substituent was in the cis coplanar conformation A trans conformation would 
also allow stabilising hydrogen bonding between the imine nitrogen and the 
hydroxyl group of the pyridinium ring.
The major function of the enzyme seems to be to enhance certain of the catalytic 
routes available to the Schiff's base, and to suppress others. The enzyme imposes 
substrate specificity and orientates the C“ -R bond (where R is any of the groups 
attached to the C^-atom) determining reaction specificity by the positioning of 
specific substate binding sites and catalytically active residues.
Snell and Metzler postulated that the catalytic abilities of PLP dependent systems 
are, to an exaggerated degree, those of the coenzyme; and that enzymic and non- 
enzymic reactions proceed by similar mechanisms.® Floss and Vederas suggest 
that the apoenzyme could bind the relatively rigid PLP-cofactor via the pyridinium 
nitrogen atom and phosphate group.^^ Attachment to one of the functional 
groups of the substrate (probably the carboxyl group), would then result in the three
point binding of the substrate aldimine (4), fixing a particular conformation of the 
C«-N bondJ^
An Example of a PLP Dependent Enzyme: Aspartate Am inotransferase
Aspartate aminotransferase (AAT) is the best understood PLP enzyme X-ray 
crystal structures are available of the active holoenzyme complex of chicken 
mitochondrial A A T j®  pig cytosolic A A T j^  and chicken heart cytosolic AAT/®  
among others.
All the aspartate aminotransferases are extremely similar in structure. The protein 
consists of two identical subunits each of which possesses two domains. The 
coenzyme is bound to the larger domain, and is situated in an open pocket near 
the subunit interface. After conversion of the Michaelis complex (6) to the aldimine 
(7) the proton of the aldimine (7) is transferred via the conjugated enamine (8) 
to ketimine (9) on the C-4'-s/ face of the coenzyme. This yields pyridoxamine 5'- 
phosphate (PMP) (10) and an a-ketoacid (Scheme 1.03). When a new a-ketoacid 
becomes available, it condenses with the PMP (10) to give a second ketimine (11). 
1,3-suprafacial proton transfer from C-4' to on the 4'-s/-face of the coenzyme 
gives the aldimine (13) which undergoes transaldimination to yield (2S)-glutamic 
acid, and the internal PLP-aldimine (3) (scheme 1,04).
Enz- ■NH2
Lys
P -0
Enz- NHg
P -0
OHP-O
(10)
Schem e 1.03: The first half-reaction of aspartate aminotransferase.
Enz—NH
OgC
O2C
Enz—NHNH
OH P -0P -0
CHCHI©
(11)(10)
OpC COp-
P -O P -O
CH
(12)(13)
Enz
CH
Scheme 1.04: The second half reaction of aspartate aminotransferase.
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X-ray crystallographic studies of mitochondrial chicken heart AAT have also 
allowed the active site residues that are important for binding to the PLP and to the 
subtrate to be identified. The protonated nitrogen atom of the pyridlnium ring forms 
a hydrogen bond with Asp222, whilst the deprotonated phenolic hydroxyl moiety is 
hydrogen bonded to the hydroxyl of Tyr225. The 2-methyl group lies in a pocket 
defined by eight amino acids, and the 5'-phosphate ester is hydrogen bonded 
within a hydrophilic pocket to six amino acids including Ser255 and Arg266. 
Arg266 neutralises the dianionic phosphate. The proximal and distal carboxylate 
groups of the physiological substrates are bound by Arg386 and Arg292 
respectively (Scheme 1.05).^^
Two genetically distinct isoenzymes of aspartate aminotransferase exist in animal 
tissue: cytosolic (cAAT) and mitochondrial (mAAT).^® The primary structures of a 
number of AATs have been completely or partially e l u c i d a t e d . T h e  amino acid 
sequence from chicken, pig, rat, mouse,^^ horse^^ and human mAAT^4 and the 
cAAT from c h i c k e n , 2 i  pig, mouse^^ and horse^^ are known, as well as those from 
E. coli B.25 and E. coli K12.26
The aspartate aminotransferases show almost 100% homology for the regions of 
the protein corresponding to substrate or coenzyme binding sites. A comparison of 
the amino acid sequence for selected regions of AAT isoenzymes2^ and the amino 
acid sequences for the Schiffs base forming region of several AATs26 are shown in 
Tables 1.06 and 1.07 respectively.
9
Arg386©-OgC. CO2-Lys258
K  NH2
Tyr70
Ser255 | ■■•v^ ” h HO
Ser107-.,\| T ^ ./"""T yrZ Z S
Arg26#’- ? - .0 3 P O " '^ Y ^  Trp140
''Q  Asn194
^  J  Ala224O ^A sp222
Tyr^O 
0 - -H " H N-Lys258
" j
Arg29f^‘OaC
Arg386©
Arg266 --O 3PO
H HOI "M"yr225
OH3
H
0^=^Asp222
Arg2 e f
©Arg292
■O3PO
H HO
<N© CH3
r y'" '^yr225
Asp222
Scheme 1.05: Residues at the active site of chicken heart mitochondrial AAT.
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Source 70 108 140 190 222 258 266 292 360 386
Human (mit) 
Chicken (mit) 
Pig (mit)
Rat (mit) 
Chicken (cyt) 
Pig (cyt)
E. coli
EYL SGTG TWGNH LHACAHNPTG FFDMAYQGF QSYAKN ERV IRP MFC GRI
EYL SGTG SWGNH LHACAHNPTG YFDMAYQGF QSYAKN ERA IRP MFC GRI
EYL SGTG SWGNH LHACAHNPTG FFDMAYQGF QSYAKN ERV IRP MFC GRI
EYL SGTG SGGNH LHACAHNPTG FFDMAYQGF QSYAKN ERV IRP MFC G£I
EYL GGTG TWENH LHACAHNPTG FFDSAYQGF QSFAKN ERV VRT MES GRI
EYL GGTG TWENH LHACAHNPTG FFDSAYQGF QSYAKN ERV VRV MFS GRI
NYL GGTG SWPNH LHACAHNPTG LFDFAYQGF SSYSKN ERV IRA DES GRV
Table 1.06: Amino acid sequence for selected regions of AAT isoenzymes.
The underlined residues correspond to the residue numbers given for cytosolic pig 
AAT. (mit = mitochondrial, cyt = cytosolic)
Source Sequence
Chicken (mit) 
Turkey (mit) 
Pig (mit)
Rat (mit) 
Human (mit) 
Chicken (cyt) 
Pig (cyt)
E. coli
VLSQSYAKNMGLY
VLSQSYAKNMGLY
VLSQSYAKNMGLY
VLSQSYAKNMGLY
VLSQSYAKNMGLY
VLSQSYAKNMGLY
VLSQSYAKNMGLY
VLSQSYAKNMGLY
Table 1.07: Amino acid sequences for the SchifTs base forming region of 
several AATs.
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1.1 The Metabolic Role of PLP dependent Enzymes.
PLP dependent enzymes are ubiquitous in nature, and occur in all species. The 
mechanisms of action of PLP dependent enzymes are of great scientific interest 
because of the integral role they play in many important physiological processes. 
This section includes examples which underline this fact, and emphasise the 
crucial part that pyridoxal 5'-phosphate dependent enzymes have to play in 
metabolism.
y-Aminobutyric acid transaminase (GABA-T) is a key PLP dependent enzyme 
involved in the regulation of the GABA-ergic system,2  ^ an important pathway in the 
mammalian central nervous system (CNS) (scheme 1.08). y-Aminobutyric acid 
(GABA) (14) is a major inhibitory neurotransmitter and there is much evidence to 
suggest that high cerebral concentrations of this compound prevent convulsions, 
by depressing the firing of neurons throughout the CNS.
NH2
HOgC
glutamic acid  ^
C O 2H decarboxylase
O
CO2H
a-ketoglutaric acid
COgH
succinic acid
NHg 
" (14)
GABA-T
oxidation
GOgH
succinic acid 
semialdehyde
GABA 
^  receptor
occupation
reduction
COgH
4-hydroxybutanoic acid
Scheme 1.08: The GABA-ergic system.
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Mammalian brain decarboxylase is directly responsible for the production of GABA 
in the GABA-ergic system. This is also a PLP dependent enzyme.
Ornithine decarboxylase (GDC) is the first and rate limiting enzyme in the 
biosynthetic pathway to putrecine and higher polyamines (Scheme 1.09).^® 
Cellular stimulation increases the activity of ODC dramatically, and promotes 
regeneration and replication. The enzyme is present at high cellular levels during 
protein biosynthesis and cell growth, but low at most other times.^f Given that 
ODC is so closely associated with growth and cell proliferation it seemed likely that 
polyamines may be required for nucleic acid b i o s y n t h e s i s . ^2 The enzyme has 
been identified as a target for cancer chemotherapy.
NH2 NH2ornithine decarboxylase ^HO2C PLP ^  2ornithine putrecine
NH2
+-CH3HO2C Ad
S-adenosylmethionine
higher polyamines
SAM decarboxylase
spermidine
Scheme 1.09: The biosynthesis of higher polyamines.
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Histidine decarboxylase (HDC) catalyses the formation of histamine (15) (a major 
receptor agonist and regulatory factor for peripheral blood circulation) from 
histidine (16).^^ Many biological reponses are associated with the overproduction 
of histamine. These include gastric secretion, allergic and hypersensitivity 
reactions.^^ The development of antagonists for histamine (antihistamines) has 
been an important area in medicinal chemistry.
NH2 ypNH
(16) (15)
DOPA decarboxylase (DDC) catalyses the conversion of many aromatic substrates 
to their corresponding amines (Scheme 1.10). For example, the formation of 
phenyiethylamine (17) from phenylalanine (18), tyramine (19) from tyrosine (20), 
tryptamine (21) from tryptophan (22), histamine (15) from histidine (16), 3,4- 
dihydroxyphenylethylamine (dopamine) (23) from 3,4-dihydroxyphenylalanine 
(DOPA) (24) and serotonin (25) from 5-hydroxytryptophan (26).^^
Dopamine is a precursor in adrenaline (27) biosynthesis, and serotonin is a 
neurotransmitter. Both compounds also act on smooth muscle tissue and the 
cardiovascular system.
OH
HO
OH
(27)
14
,0 HOHNHg ^
H2N
(19)(20)
H'jj 
HOgC
(21)(22)
OHOH
.OHOH
(23)(24)
NHg
OHOH (25)(26)
Scheme 1.10: Reactions catalysed by DOPA decarboxylase.
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The racemases are an important group of PLP enzymes, catalysing the 
interconversion of (2S)- and (2f?)-amino acids. They are common in most 
prokaryotes where they play a fundamental role in the biosynthesis of 
peptidoglycan (a cell wall component).^^ The racemases present a useful target 
for chemotherapy, and alanine racemase in particular is the target of many 
antibacterial agents,^® such as {2R)-cycloserine (28),^^ 0 -carbamyl-(2 H)-serine 
(29)^® and phosphoalanine (30).^^
HOgC
16
1.2 Mechanism  Based Inhibitors of PLP dependent enzym es.
Mechanism based or suicide inhibitors of PLP dependent enzymes are potential 
drug candidates due to the pharmacological and therapeutic utility of inhibiting 
specific PLP enzymes. These inhibitors are substrate analogues and can also be 
useful tools in investigating the mechanism of specific enzymes. As already 
mentioned (section 1.0) the role of PLP is to stabilise carbanionic intermediates 
that form during the catalytic process. Inhibitors that possess functional groups 
which become activated by their proximity to an enzyme generated carbanion can 
breakdown to yield a reactive species that may react with an active site amino acid 
side chain, or with tightly bound PLP coenzyme. Either of these processes will lead 
to the inactivation of the enzyme, in the first instance blocking the active site with an 
un reactive species; or in the second case causing the coenzyme to become 
unavailable to bind substrate. Functional groups commonly used in the design of 
such inhibitors include acetylenic, olefinic, p-halo substituents and other leaving 
groups, nitriles, aryl sulfoxides, dihydroaromatics and phosphonoamino acids.^®
In the first half reaction of transamination (Scheme 1.04) catalysis proceeds 
through the substrate-PLP anion and the product a-amino acid-PMP enzyme 
complex (10). Both of these intermediates have the potential to be activated as 
suicide substrates. This is indeed what is observed in both olefinic and acetylenic 
amino acid analogues. The olefinic analogues include vinyl glycine (31),^^ (E)- 
methoxy vinyl glycine (32)^0 and p-methylene aspartate (33).^^ The accepted 
mechanism for inhibition of AAT by vinyl glycine (31) is shown in Scheme 1.11.
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The acetylenic analogues include the natural product (2S)-propargyl glycine 
(34)."^2 The mechanism of inactivation is shown in Scheme 1.12.
Enz— Enz—NH
NHp O3PO
(31)
Enz—Lys-NH E " " L y s . N H
PMP
Schem e 1.11: The Inhibition of AAT by vinylglycine.
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Enz—B:
O3PO
H
CH3H
Enz-B
O3PO
N CH3
X-EnzEnz—B> ^
'■ Â -—  H ^ N
O3PO
H
N CH3 H
Enz- B.
OsP O ^ '^ 'Y V '
^ ^ C H 3H
Enz—B:L
-  H <N ,
- 0 3 P 0 - Y y °
^ N '^C H 3H
HLCO2Enz-B
2-O3PO
%  CH3H
Schem e 1.12: The inhibition of AAT by (2S)-propargyi glycine.
Suicide substrates which possess a good leaving group at cP are some of the most 
common. These compounds can undergo a facile elimination reaction to generate 
an olefinic intermediate. Examples of this class of inhibitor are (2 S ) -3 - 
chloroalanine (35)^^>^^ which inhibits alanine aminotransferase, and (2 S)-serine- 
O-sulfate (36) which inhibits aspartate aminotransferase.^^
NHg
H - j k ^ C I
NHg
H - / O 0 SO3H
HOgC HOgC
(35) (36)
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it was originally thought that the inactivating species was the aminoacryi-PLP 
intermediate, which would undergo a putative Michael reaction with an enzyme 
bound nucleophile. Although this is the case with some enzymes, such as serine 
hydroxymethyltransferase, Metzler and his coworkers have shown that the 
inhibition of aspartate aminotransferase is not due to the occurrence of a Michael 
reaction.^® Bright and coworkers have used the nitro group of 3-nitroalanine as an 
inactivator of aspartate aminotransferase and alanine aminotransferase. 
Alanine aminotransferase is also inhibited by cyc/oserine (28),^® while aspartate 
aminotransferase is inhibited to varying extents by a - and y-cyc/oglutam ic  
acids.^®‘^2 a-Cyc/oglutamate (Scheme 1.13, (37)) is believed to acylate an active 
site bound nucleophile to give a stable inactivated complex, whilst 
y-cyc/oglutamate is thought to form an oxime of p-aminooxyglutamate with PLP.
,:B-Enz
0 -N
HO2C OH
O3PO
PLP
■:B - Enz0 -N OH B-Enz
03PO
Scheme 1.13: Mechanism of inactivation of AAT by a-cycloglutamate.
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Various analogues of GABA inhibit GABA-transaminase. These include (3-chloro-,
3-phenyl, y-acetylenic and y-vinyl GABA as well as ethanolamine O-suifate.^^ 
Mammalian GABA-transaminase Is inhibited by the naturally occurring product 
gabaculine (38) via an interesting aromatisation mechanism to give the conjugated 
PMP adduct (Scheme 1.14, (39 )).54-55
:B- Enz
GABA-T
PLPNH2
(38) N© CH3
(39)
Scheme 1.14: Mechanism of inactivation of GABA-transaminase by gabaculine 
(38).
PLP dependent racemase enzymes are important because they are involved in the 
biosynthetic pathway leading to peptidoglycan. Many suicide substrates are 
known for the racemases, including ^-substituted alanines for alanine racemase^^" 
and phosphoalanine (for gram positive alanine racemase only).^^>®^ 
Phosphoalanine is thought to inhibit alanine racemase via an initial reversible 
formation of a weak complex which slowly isomerises to a stoichiometric complex 
that dissociates extremely slowly. The complex is not reducible with borohydride.^^
Enzymes which catalyse a,(3-elimination occasionally undergo an abortive reaction 
with a physiological substrate. For example, threonine deaminase is very slowly 
Inactivated by (2S)-serine approximately once every 10^ turnovers,®'' note that a
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similar situation occurs with 3-chloroaianine.®^ In contrast, (2S,3f?)-threonine does 
not cause inactivation, presumably as the intermediate formed is less susceptible 
to Michael addition or enamine condensation to give the Schnackerz type product 
(40) (Scheme 1.15).®^
Enz—NH3/ 's ^ C 0 2 ' HaN-Enz
CH3
E n z .^ x - ^ C 0 2 ’CO2Enz—N2H
-HX
O3PO
Enz
O3PO
(40)
Schem e 1.15: Two possible mechanisms for the inactivation of enzymes that 
catalyse a,p-elimination reactions. Route a causes the modified coenzyme to be 
covalently bound to the enzyme, and route b leads to the Schnackerz adduct (40).
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E. coli trypîophanase is irreversibly inhibited by thfiuoroaianine.®^ It is proposed 
that the difluoroaminoacrylyl-PLP-aldimine complex is more susceptible to 
nucleophilic attack at C-3 by an enzyme bound base, than to hydrolysis at the 
aldimine carbon atom. The enzyme p-cystathionase is irreversibly inactivated by 
the fungal toxin rhizobiotoxin (Scheme 1.16, (41)).®^ The alkoxyvinylglycine 
analogue rhizobiotoxin may undergo initial C^-H abstraction, and then an addition 
and elimination sequence, similar to that for (E)-methoxyvinylglycine (32) with 
aspartate aminotransferase. p-Cystathionase is also irreversibly Inhibited by 
trifluoroalanine, and tryptophan synthase is subject to suicide inhibition by 
trifluoro-, trichloro- and dichloroalanine.®® E. coli tryptophan synthase also reacts 
with cyanoglycine, causing inhibition which is reversible upon dialysis or gel- 
filtration. The inactivated coenzyme is presumed to be a stable p-imine PLP adduct
(4 2 )6 7
HN
:p -o
(42)
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OH
NH2 NH2 
HO2C
(41)
Enz-Nu:
1) p-cystathionase
2) -H+
2-O3POPLP
NH2Enz—Nu .0 ,0 H
NuCO2 Enz'
InactivatedenzymeO3POO3PO
Scheme 1.16: The inactivation of p-cystathionase by rhizobiotoxin (41).
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1.3 The Classification of PLP Enzymes.
in 1994, P. Christen and his coworkers proposed that most PLP dependent 
enzymes can be assigned to one of three different "families" of homologous 
proteins.®® The relationships between the different PLP enzymes were deduced 
by alignment and comparison of their amino acid sequences and 3D structures. By 
also comparing the reactions catalysed by these enzymes (Scheme 1.17), Christen 
deduced that the regiospecificity of the enzymes was directly related to the 
membership of one of these "families". Accordingly the enzymes catalysing 
reactions at C^  ^were assigned to the so-called a-family; those acting at CP to the 13- 
family; and those acting at CY to the y-family. There are some interesting 
exceptions to this rule, and indeed some PLP dependent enzymes do not seem to 
belong to any of the groups.
NH2
H 0 2 C ^ X
PLP -----► -----decarboxylases
NH2
NH2
l-MwH 0 2 C ^^X
PLP — ^aminotransferases H 0 2 C '^ X
NH2 PLP -----► -----►serine hydroxy methyl transferase
NHg
JH02C'^
Scheme 1.17a: Some types of reaction catalysed by PLP dependent enzymes.
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NHg PLP O
a) enzyme H^3C""^ C02H  ^ ^^ 3
i. tryptophanase X = indole
ii. tyrosine phenol-lyase X = phenol
iii. threonine dehydratase X = -OHiv. tryptophan dehydratase X = Indole
V. cystathionine p-synthase X = homocysteine
_  P ^ .Y   NH;
enzyme  ^ ^
i. tryptophan synthase X = -OH, Y = indole
ii. cysteine synthase X = O2CCH3, Y = -SH
PI P Y  H;N Y
HO;C X ^
i. threonine synthase X = -OPOs '^, Y = -OH
NH2 PLP O
d) H02C^ '*^ '^''~^  ^ enzyme  ^ *^ 3^
i. cystathionine y-synthase X = -cysteine
H...J PLP, Y _ „ JHO;C'*'^ '^ X enzyme HO;C**‘^ '^ Y  ^
i. 0 -succinylhomoserine(thiol)-lyase X=-02CCH2CH2C02H, Y = -cysteine
ii. Oacetylhomosehne(thiol)-lyase X = -O2CCH3, Y = methanethiol
Schem e 1.17b: Some other types of reaction catalysed by PLP dependent 
enzymes.
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The a -Fam ily  of PLP Dependent Enzymes.
The a-family has, by far, the most members of all the PLP dependent groups (Table 
1.18), including the aminotransferases and the group II decarboxylases. Many of 
these enzymes have 3D structures available for comparison, and the structural 
similarities can be seen clearly between different types of enzyme.
Most aminotransferases (excluding branched chain and D-amino acid)®®>^ ® 
Group II amino acid decarboxylases 
Tryptophanase 
Tyrosine phenol-lyase^^
Glycine hydroxymethyltransferase 
1 -Aminocyclopropane-1 -carboxylate synthase^^ 
2-Amino-6-caprolactam racemase 
Glutamate-1 -semialdehyde 2,1 -aminomutase 
Isopenicillin N-epimerase 
2 ,2-dialkyl decarboxylase^®
4-Amino-4-deoxychorismate synthase^" -^^®
G lycine-C-acetyltransferase 
5-Aminolevulinate synthase 
8-Amino-7-oxononanoate synthase 
The gene product of cobC (cobalamin synthesis)
The gene product of nifS (nitrogen fixation)
The gene product of malY (abolishes induction of the maltose system)
Table 1.18 : PLP dependent enzymes belonging to the a-family.
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In the a-family the PLP binding lysine residue occurs between residues 209 and 
256 of the various members. The most intensely studied members of the a-family 
are the aminotransferases (or transaminases), which have already been discussed 
(page 6 and Scheme 1.17a), as have examples of the decarboxylases (Scheme 
1,17a), Serine hydroxymethyltransferase catalyses the decarboxylation of 
aminomalonate as shown in Scheme 1.17a. Tryptophanase and tyrosine phenol- 
lyase catalyse reactions of type a) (Scheme 1.17b).
The (3-Family of PLP Dependent Enzymes.
The p-family has seven members, and includes threonine synthase (Table 1.19). 
Parsot first postulated the evolutionary connection of these enzymes in 1967.^®»^^ 
These suggestions were later upheld by Bork and Rohde.^® If these enzymes are 
related in an evolutionary context, then they may be distantly related to an archaic 
enzyme with very broad specificity.
(2S)-Serine dehydratase 
(2R)-Serine dehydratase 
Threonine dehydratase 
Threonine synthase 
Tryptophan dehydratase 
Tryptophan synthase (p-subunit) 
Cysteine synthase (isoenzyme A and B)
Table 1.19: The p-family of PLP dependent enzymes.
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The p-family has the PLP binding lysine lying between amino acid residues 41 and 
118. This is clearly very different from the a-family, and may reflect the alternative 
PLP arrangement needed for the enzymes to carry out reactions at the C«-centre 
rather than at the CP-atom. The serine dehydratases, threonine dehydratase and 
tryptophan dehydratase catalyse reactions of type a (Scheme 1.17b). Tryptophan 
synthase and cysteine synthase catalyse reactions of type b, and threonine 
synthase catalyses a reaction of type c.
The y-Fam ily of PLP Dependent Enzymes.
This is the smallest "family" of enzymes with only four members (Table 1.20). 
Interestingly Bork and Rohde have shown significant sequence similarities 
between threonine synthase and O-acetylserine sulfhydrolase.^® This may 
suggest that the p- and y- families are more closely related than Christen’s work 
would suggest on first examination. On the other hand, the fact that threonine 
synthase also catalyses a change at the CY-atom of its substrate may account for 
this similarity.
0-Succinylhomoserine(thiol)-Iyase 
0-Acetylhomoserine(thiol)-Iyase 
Cystathionine p-lyase 
Cystathionine y-lyase
Table 1.20: The y-family of PLP dependent enzymes.
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In the y-family PLP-Lys occurs in the same sequence segment as in the a-family, 
thus hinting at a possible evolutionary relationship between the two. This could be 
further investigated by comparison of the 3D structures of a - and y- family 
members, when the structure of a y-family member becomes available. 
0 -succinylhomoserine(thiol)-lyase and 0 -acetylhomoserine(thiol)-lyase catalyse 
similar reactions of type e (Scheme 1.17b). Cystathionine p-synthase catalyses a 
reaction of type a (acting at the p-carbon as the name suggests), and the closely 
related cystathionine y-synthase catalyses the similar reaction d.
Exceptions to the "Family Rule".
As already mentioned, a few PLP dependent enzymes do not belong to the family 
that would be suggested by their regioselectivity. Tryptophanase, tyrosine phenol- 
lyase and 4-amino-4-deoxychorismate synthase are all members of the a-family by 
sequence, yet catalyse p-elimination reactions; whereas 1 -aminocyclopropane-1 - 
carboxylate synthase, another a-family enzyme, catalyses an a,y-replacement. 
Similarly, threonine synthase which as we have seen assigned to the p-family, 
catalyses a p,y-replacement reaction; and cystathionine p-lyase (a y-family 
member) catalyses a p-elimination.
With increased access to sequence searching and alignment software, the 
evolutionary history of threonine synthase and other PLP dependent enzymes is 
gaining more attention. Using up to date computer technology it may be possible 
to reliably fit related enzyme sequences to already solved structures to increase 
our understanding of these enzymes.
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1.4 Introduction to Threonine Synthase.
Pyridoxal 5'-phosphaîe enzymes had been known about for over two decades (see 
section 1.0 ) when, in 1960, Flavin and Slaughter reported a new and quite different 
pyridoxal 5'-phosphate dependent enzyme. In their words, the enzyme "...which 
will be called threonine synthetase, catalysed an elimination of orthophosphate 
coupled to isomérisation from a- to p- hydroxy compound, to yield threonine from 
O-phosphohom oserine.".^® Now more commonly referred to as threonine 
synthase (EC 4.2.99.2), the enzyme is known to stereospecifically catalyse the 
conversion of (2S)-0-phosphohom oserine (43) to (2 S)-threonine (44) and 
inorganic phosphate in the final step of threonine biosynthesis in plants (Scheme 
1.21).2
' ' O H
HOpC HOpC
Scheme 1.21 ; The reaction catalysed by threonine synthase.
The Biosynthesis of Threonine from Aspartic Acid.
For man, (2S)-threonine (44) is one of the nutritionally essential amino acids 
(Table 1.22), and must be supplied in the diet. An inadequate supply leads to a 
negative nitrogen balance by inhibiting protein synthesis. This occurs when the 
ribosome-mRNA nascent polypeptide complex suspends its operation at the point 
where a missing amino acid should be incorporated. Other amino acids then
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accumulate and are shunted into degradative metabolic pathways, causing a net 
loss in nitrogen.
Threonine is biosynthesised in five steps from aspartic acid (Scheme 1.23). These 
steps also have a role in the biosynthesis of lysine, methionine and isoleucine.®® 
(2S)-Aspartic acid (45) is phosphorylated by aspartate kinase at the expense of 
ATP to give (2S)-aspartic acid p-phosphate (46). The enzyme aspartate 
semialdehyde dehydrogenase reduces this activated compound to (2S)-aspartic 
acid p-sem ialdehyde (47). (2S)-aspartic acid p-sem ialdehyde (47) is an 
intermediate in the biosynthesis of lysine (48), however in this case the amino acid 
(47) is reduced by homoserine dehydrogenase to yield (2S)-homoserine (49). 
Phosphorylation by homoserine kinase yields (2S)-0-phosphohomoserine (43), 
which is converted to threonine (44) by the action of threonine synthase. 
Phosphohomoserine (43) is also a precursor of methionine (50), and (2S,3R)-  
threonine (44) lies on the isoleucine (51) biosynthetic pathway.
lie Leu Lys Phe Met Cys Thr Trp Val
Child
Man
Woman
WHO*
90.0
10.4
5.2
3.0
9.9
7.1
3.4
90.0
8.8
3.3
3.0
90.0
4.3
3.1
2.0
85.0
1.3
4.7
1.6
11.6
0.5
1.4
60.0
6.5
3.5 
2.0
30.0
2.9
2.1
3.0
85.0
8.8
9.2
Table 1.22: The minimal requirements of human beings for essential amino acids 
in mg kg'"^  World Health Organisation norms.
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(2S)-Aspartic acid
Mg2+, ATP
Mg2+, ADP
NH2
(45)
Aspartate kinase
NHg O
(2S)-Aspartic acid p-phosphate 
NADPH + H+
HHOgC;ï»0 ^ 0-P '°"O^H
NADP+  ^
(2S)-Aspartic acid p-semialdehyde
(46)
Aspartate semialdehyde dehydrogenase 
NHg O
NADPH + H+ ■
NADP+ 
(2S)’Homos0rine
Mg2+, ATP -  
Mg2+, ADP -* 
(2S)-0-Phosphohomoserine
(47)
Homo serine dehydrogenase 
NH2 
(49)
Homoserine kinase
HOgC
o
OH
(43)
Threonine synthase
(2S,3fl)>Threonine
HgN .OH
H"'W"HHO2C CH3
(44)
HO2C
Lysine (48)
NHs
Methionine (50)
NH;H-ii
HOgC
Isoleucine (51)
Schem e 1.23: The biosynthesis of threonine from aspartic acid.
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Threonine Synthase from Bacterial Sources.
The gene for threonine synthase has been isolated and sequenced from several 
sources including y e a s t , Brevibacterium lactofermentum,^^ E. co//,®^ Bacillus 
subtilis,^^'^^ Corynebacterium glutamicum,^^ Serratia marcesens^^ and 
Pseudomonas aeruginosa.^^ When the amino acid sequences of the enzyme from 
various sources were compared, the enzymes showed remarkable homology, 
especially for the residues close to the active site (Table 1.24). The lysine residue 
(bold and underlined) that forms the internal aldimine with pyridoxal 5'-phosphate 
is conserved in all cases, as are the phenylalanine and aspartic acid residues 
flanking it. The positions 5 and 4 residues upstream of the Lys-PLP are occupied 
by a proline residue and a threonine residue respectively. In all sequences 
published to date these amino acids are conserved.
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E. coli a a f a f p a p v a n v e s d v g c l e l f h g p t l a f k d f g g r f m a q m l t h
* * * * * * * * *  * * * * * * * * * * * * * * * * * * * * * * * * * * *
s. mar. a a f e f p a p v a k v t d d v s c l e l f h g p t l a f k d f g g r f m a o m l a e
*  *  *  * * * * * * * * * * * * *  *
P. aer a h d a s g a a a p v e r r t n g c v e l f h g p t l a f k d f a l o l l g r l l d h
* * * * * * *  *  *  *  *  *  *  *  *  *
S. cer. e v t p l v q n v t g d k e n l h i l e l f h g p t y a f k d v a l o f v g n l f e y
*  *  *  * * * * *
Br. lact. PLIp l l n i s k o l g v o l y g k y e g n n p t g s f k d r g m v m a v a k a k e
*  *  *  *  *  *  *  *  *  *  *  *  * * * * * * * * * * * * * * * * * * * *
Bac. sub. PLi h l p k l s e o l g i e l h v k t e g v n p t g s f k d r g m v m a v a k a k e
*  * * * * * *
C. glu. FNSEDIVPVTELEDNIYLGHLSEGPTAAFKDMAMQLLGELFEY
*  *  *  *  *  *  *  *  *  *  *  *  *  *  * * * * * * * * * * *  *  *  *
M. gly.______QDAEDITPTYKLEDDLYLLSLSNGPTLAFKDMAMQLLGNLFE
E. coli Escherichia coli S. mar. - Serratia marcesens
Bac sub. Bacillus subtilis P. aer. - Pseudomonas aeruginosa
Br. lact. Brevibacterium flavum M. gly. -Methylobacillus glycogenes
C. glu. Corynebacterium glutamicum S. cer. -Saccharomyces cerevisiae
Table 1.24: Sequence homology of threonine synthase from bacterial sources. 
Stars indicate conserved residues between sequences.
Threonine synthase was first purified 500-fold iromNeurospora in 1 960 /^  through 
a series of acetone and ammonium sulfate fractionations, followed by ion 
exchange chromatography. A crude preparation of the enzyme was described from 
Brevibacterium flavum in 1968.^^ There were no reports of a purification of 
threonine synthase to homogeneity until Parsot and his co-workers described a 
preparation of the enzyme from E. coli K12 strain Tir 8®  ^ (a constitutive mutant for 
the enzyme).^^ The purification was carried out by a variety of ion-exchange
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chromatography steps. Threonine synthase from E. coli was found to have a 
molecular weight of between 46 000 and 48 000 Daltons as determined by SDS- 
PAGE, and of 47 060 as deduced from the amino acid sequence. Han and 
coworkers purified the enzyme from Corynebacterium glutamicum. The molecular 
weight of the protein was reported to be 54 000 Daltons as determined by SDS- 
PAGE and amino acid sequence.
Threonine Synthase from  Plant Sources.
There is substantial interest in the aspartate pathway of plant species due to man's 
desire to improve the nutritional qualities of some crops. Cereals are deficient in 
lysine and methionine, and legume seeds exhibit low levels of methionine.^^ In 
addition, an understanding of the aspartate pathway and particularly of threonine 
synthase in plant tissues may be of help in the design and synthesis of effective 
and selective herbicides. Wallsgrove and coworkers have shown that the enzymes 
involved in the aspartate pathway are located in the chloroplasts of plants.^^
Various groups have succeeded in purifying threonine synthase (TS) from plant 
sources and these are summarised below (Table 1.25). The enzyme was first 
detected in sugar beet and radish l e a v e s , a n d  has since been partially purified 
from Lemna m in o r ,pea,®® barley,®^ Lemna pausicostata^^ and soybean.®®
In all plants examined to date, threonine synthase shows an almost absolute 
requirement for S-adenosylmethionine (SAM). SAM appears to act as an allosteric 
activator, with a Hill coefficient of 2.0-2.5. Half maximal activation occurs between 
40 and 200 pM. Plant TS has a pH optimum of around 8.0 and no isoenzymes 
have yet been detected.
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Source Km (pM) Vmax Hill coefficient
Sugar beet 2 700 38.2 nmoles/h
+SAM 2 200 534.3 nmoles/h -
Pea 2 200 2.1
+SAM 670 4 fold increase
Lemna +SAM 5.1 47.2 pmol/40 min 2.5
Table 1.25: Kinetic properties of threonine synthase from higher plants. The Hill 
Coefficient is a measure of cooperativity, where the binding of ligand (in this case 
SAM) to protein is at 50% saturation.
Threonine Synthase Expression in Mammalian System s.
Non-ruminant diet can be significantly improved by feeding rations supplemented 
with the essential amino acids, and especially lysine and threonine. The ability to 
introduce pathways for the biosynthesis of these amino acids into animal cells 
would eliminate the need for this s u p p l e m e n t a t i o n . R e e s  and Hay recently 
described the expression of the aspartokinase and threonine synthase gene in 
mouse 3T3 c e l l s . T h e s e  cells were then able to grow on threonine deficient 
medium containing (2S)-homoserine.
There is no known case of threonine synthase or homoserine kinase occurring 
naturally in mammalian systems, however, it has been noted that (2 S )-0 -  
phosphohomoserine (43) is an antagonist of A/-methyl-D-aspartate (NMDA) in rat 
b r a i n . P h o s p h o h o m o s e r i n e  has been the subject of a patent for its use in 
conjunction with the drug levemopamil. The administration of these compounds 
together is used to treat damage to neurons in patients with AIDS related dementia,
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myelopathy, peripheral neuropathy and vision loss, by reduction of the gp120 
responsive rise in calcium ionsJ®"^
The Threonine Operon of E. colL
Studies over the past 40 years have shown that amino acid biosynthesis in 
bacteria is regulated by controlling the catalytic efficiency of certain key enzymes, 
and by controlling the levels of these enzymes via gene expression.^®® Threonine 
biosynthesis is no exception, and the method of control has been studied in 
yeast,"*®® Corynebacterium g l u t a m i c u m , B r e v i b a c t e r i u m  f l a v u m , S e r r a t i a  
m a r c e s c e n s , ^ ^  Pseudomonas  a e r u g i n o s a , B a c i l l u s  subf/7/s^^ and 
Brevibacterium lactofermentum.'^^^ By far the best understood is the control of 
threonine biosynthesis in E. coli. This is discussed here.
It is established that (2S,3E)-threonine is biosynthesised in five steps from aspartic 
acid (scheme 1.23). It has been found that the genes encoding most of the 
enzymes that catalyse these steps exist as an operon (Scheme 1.26).
The thrA gene encodes the threonine-sensitive bifunctional aspartate kinase I - 
homoserine dehydrogenase j.n o .m  E. coli K12 contains two additional aspartate 
kinases and one additional homoserine dehydrogenase. The biosynthesis of the 
bifunctional aspartate kinase II - homoserine dehydrogenase II Is regulated by 
methi oni ne . " * The  activity and biosynthesis of aspartate kinase III is regulated by 
lysine.^
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(2S)-Aspartlc acid (45)
thrA aspartokinase I
metL  ^^ aspartokinase II 
lysC aspartokinase III
(2S)-Aspartlc acid p-phosphate (46)
asd aspartate semialdehyde dehydrogenase
(2S)-Aspartic acid p-semiaidehyde (47)
thrA
metL
homoserine dehydrogenase I 
homoserine dehydrogenase II
(2S)-Homoserine (49)
thrB homoserine kinase
(2S)-OPhosphohomoserine (43)
thrC threonine synthase
(2S,3A)-Threonine (44)
Scheme 1.26: Enzymes of the threonine biosynthetic pathway.
The thrB gene encodes homoserine kinase, which catalyses the phosphorylation of 
(2S)-homoserine to yield (2S)-0-phosphohomoserine (43). It has an aa-structure, 
each subunit having a mass of around 29 000 D a l t o n s . ^ T h e  purified protein 
requires Mg®+, and K+ stimulates activity."*^® ThrB has been sequenced, and the 
amino acid sequence de duce d . ^Homos e r i ne  kinase is competitively inhibited 
by threonine with an apparent K| of 0.6 mM.'*"’  ^ Product inhibition is not observed.
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and the threonine analogues (2f?,3f?)-threonine, glycylthreonine, 3- and 4- 
hydroxybutyrate, 3-amlnobutyrate and O-methyl threonine display no inhibitory 
effect even at high concentrations
The coordinate regulation of the threonine biosynthetic enzymes was first 
demonstrated in Salmonella typhinurlum ar\6 E. coll by Freundlich in 1963^"*^ It 
was observed that both threonine and isoleucine were required for attenuation. 
The structural genes encoding the threonine biosynthetic enzymes have all been 
identified and mapped.^ The thr operon of E. co//consists of thrA, thrB and 
thrC at 0 min on the linkage map. The asd  gene which encodes aspartate 
semialdehyde dehydrogenase lies at 75 minutes."*®®
The order of transcription: thrA, thrB, thrC has been established by analysis of 
nonsense mutations and phage Mu insertions in the cluster,"* "*® and by analysis 
of a 1 phage insertion. When X phage insertion was directed to the thr regulatory 
region it was found that it lay to the left of thrA (that is trpR-X-thrA),  and 
pleiotropically affected the expression of both thrA and thrB. Deletion analysis 
confirmed these findings, and the genetic fine structure of the thr operon has been 
deduced by deletion mapping."*®® Complementation analysis of the thrB and thrC 
regions showed that these genes consisted of single cistrons, whilst thrA was 
composed of two cistrons specifying a single polypeptide chain. The findings are 
in accord with the bifunctional character of the thrA gene product.
Various regulatory mutants of E. co//have been studied,^® "^"*®® and have identified 
a regulatory region that precedes the thr operon structural genes. Mutation in this 
region causes pleiotropic effects on thr expression. It was originally thought that 
these mutants were classical operator mutants, in an analogous manner to those 
isolated in the frp and lac opérons. ®^^ >^ ®^  However, because no apo-repressor 
mutants have been isolated, and because all mutations analysed to date lie in the
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thr attenuator; it does not appear that the thr operon of E. coli is regulated by a 
repressor-operator mechanism.
The thr operon promoter lies approximately 230 nucleotides upstream of thrA.^^  ^
Regulation of transcription termination is a common regulatory mechanism/®® and 
can either be rho-dependent or rho-independent, depending upon the in vitro 
termination efficiency. As in other rho-dependent terminators the thr regulatory 
region contains extensive dyad symmetry and the characteristics of being G-C rich, 
followed by a stretch of A-T base pairs at -63 to -30 bases. When described into 
RNA, the terminators give rise to secondary structure containing a stem and loop 
with a run of uridine residues at the 3'-end (necessary for efficient termination 
(figure 1.27)).’*®®*'*®'* In wYro transcription studies found the termination efficiency of 
the f/?r attenuator to be around 90%.^®^
5'-AAACACAGA-UUUU-3'
Figure 1.27: The secondary structure of DNA from the thr regulatory region from 
-71 to -27 bases, presented in the most stable conformation to maximise base 
pairing in the RNA termination structure.
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In addition to the promoter and attenuator, the thr regulatory region contains two 
features relevant to attenuation: a sequence encoding a leader peptide, and a 
pause site for RNA polymerase. Positions -147 to -82 encode the putative leader 
peptide of 21 amino acids. This peptide contains eight threonine and four 
isoleucine residues. Eleven of these twelve codons occur consecutively, and their 
replacement by histidine and tyrosine codons produced mutants showing a loss of 
regulation by threonine and isoleucine.
The thr regulatory region contains several regions of overlapping rotational 
symmetry. The first lies in the attenuator region at -63 to -30 bases, the second at 
-93 to -49 bases, overlapping the attenuator. This allows the formation of two 
mutually exclusive secondary structures; formation of the first causing termination, 
and formation of the second blocking the attenuator region allowing transcription to 
proceed through into the structural genes. Incomplete regions of rotational 
symmetry include -99 to -90 bases and direct repeats -130 to -121 and -112 to 
-103. A pause site for RNA polymerase has been shown to lie within the region -90 
to -80 b a s e s . T h e  significance of this site is not known, but may be to facilitate a 
link between the transcription and translation of the leader region.
A model has been proposed for the multivalent regulation of thr operon expression 
involving coupled transcription and translation of the leader region and the 
consequences of this coupling on RNA secondary structure formation and 
transcription te rm in a t io n .T h is  is a similar model to those proposed for the other 
amino acid biosynthetic o p é r o n s . The RNA encoded by the thr regulatory 
region from -147 to -27 bases has four possible secondary structures (Figures 
1.28a and 1.28b) reflecting a) attenuation; b) transcription through the attenuator; c) 
and d) no translation of the leader RNA.
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a)
1
1 ^  ^  ^  lie
AUGAAACGCAUUAGCACCACCAUUACCACCACCAUCACCAUUACCACAGGUAACGGUGCGGGCUGACGCGUACAGGAAACACAGA — UUUU 
-140 * _120 ■ ^8 .iôo ^ * -80
G A 
U C
I c  A
\  C— G 
A — U 
C— G 
G— C 
C— G 
G - G  
3  G— G 
G— G A—U 
A — U 
A — U  
A — U
b)
aGCAAa
G— GG—G
G— G
G— G
G—G
U— A
AUGAAAGGGAUUAGGAGGAGGAUUAGGAGGAGGAUGAGGAUUACGACAGGUAAGe-  GUGAGAGUGGQ^Ptni II II II II II H il il i 
-140 * 1A *1B  V  4-120 -100 -30
Figure 1.28a: Control of thr operon expression by attenuation. Model a) shows 
attenuation and b) shows transcription through the attenuator. The 
bar in a) indicates the coding region for the leader peptide. The 
numbers above the sequence denote the positions of the 
threonine and isoleucine codons in the leader peptide. The boxed 
areas indicate regions involved in secondary structure formation.
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c)
1B
a " ail
0 -  G C— G 
A — Lf
G A 
U G
l e  A 
^  C— G 
A — U 
G— G 
G— G 
G— G 
G— G 
G—  G 
G— G 
A —"U 
A — U 
A — U 
A — U
AUGAAAGGGAUUAGGAGCAGCAUUAGGAGGAGGAU G ~  GCGGGGGUGAGGGGUAGAGGAAAGAGAGA — U UUU 
1A
d)
GA A
0— G0 -  GA — U
1A U— AU— AA— GG— G0— G
A— UAUGAAAGGGAUUAGGAGÛ— i
G A 
U G
I g  a  S  G— G 
A — U 
G— G 
G— G 
G— G 
G— G 
G—  G 
G— G 
A — U 
A — U 
A — U
* " u u u u
Figure 1.28b: Control of thr operon expression by attenuation. fi/Iodels c) and 
d) show poor or no translation of the ieader RNA.
Under conditions of threonine and isoleucine excess, transcription initiating at the 
thr promoter is coupled to the translation of the leader peptide terminating at the 
UGA codon at -82. The formation of the RNA termination structure (stem 3-4, a) is 
favoured due to ribosomal blocking of the pairing bases -58 to -49 and -93 to -84.
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If threonine and isoleucine become growth limiting, the ribosomes slow down or 
stall in the region of consecutive threonine and isoleucine codons. This allows the 
formation of stem 2-3 (b), precluding the formation of the RNA termination structure. 
The f/jr structural genes are therefore expressed.
When the leader RNA is not translated, transcription is efficiently terminated by 
formation of RNA secondary structures stem 1A-2 (c) or 1B-2 (d), allowing formation 
of the termination structure. Evidence for this postulate has been obtained in both 
the and opérons.
A G-C rich region of dyad symmetry followed by a stretch of six uridine residues 
occurs 21 base pairs after the stop codon of This region could form a stable
stem and loop secondary structure, a characteristic rho-dependent transcription 
termination site, and could be the thr operon termination region.
Amplification of the thr operon has been carried out by various g r o u p s , " * a n d  
has been the subject of patents."*^®>"*^® An understanding of the mechanisms of 
control of the thr operon is allowing the application of molecular biology to form 
threonine accumulating mutants of microorganisms.
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Threonine Synthase Has an Associated Dehydratase Activity.
It has been shown that threonine synthase of Bacillus subtilis can also catalyse the 
deamination of (2S)-0-phosphohomoserine (43) to yield a-ketobutyrate (52).
NH2 o
(43) (52)
This is a distinct activity from the usual route to a-ketobutyrate via threonine 
deaminase, and has been shown not to pass through a threonine intermediate.
phosphohomoserine (43)
phosphohomserine/ \h re o n in e  synthase 
deaminase /  \
/ - N H 3 -P 04® \
isoleucine (51)-<— — a-ketobutyrate deaminase (44)- NH3
This phophohomoserine deaminase activity was shown to be a lesser activity of 
threonine synthase, as the two activities are shown to co-purify, to be of the same 
molecular weight, to co-inactivate with heat, and to display the same Km for the 
substrate phosphohomoserine (43)."*®® Mutational evidence was also cited.®®’"*®^  
The associated deaminase activity has not been reported in any other organism to 
date.
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The Postulated Mechanism of Threonine Synthase.
HgN CH 3
------------- * -  H"')— (I'O H  +  p .
HOgC H '
(43) (44)
The first mechanistic studies into threonine synthase were carried out by Flavin and 
Slaughter in 1960 on the Neurospora enzyme."*®® When the reaction catalysed by 
threonine synthase was carried out In "*®0-labelled water, "*®0-label was 
incorporated into threonine, but not into the eliminated phosphate. Phosphate is 
therefore released by a non-hydrolytic elimination, with cleavage of the C-O bond 
of the phosphate ester. When the reaction was carried out in deuteriated or tritiated 
water, one non-exchangeable solvent hydrogen was incorporated into the 
y-position of threonine. This indicates that the reaction proceeds through an 
intermediary derivative of vinylglycine (31). A second solvent hydrogen was 
introduced at C“ of threonine. From the incubations conducted in deuterium oxide, 
it was evident that threonine synthase introduced two atoms of deuterium into the 
product. It could therefore be deduced that no significant internal proton transfer 
occurred.
Fuganti later investigated the reaction of threonine synthase with 
phosphohomoserines stereospecifically labelled with tritium at each of the C-3 
positions.^®® He found that the 3-pro-S hydrogen was removed, and that the 3- 
pro-R hydrogen was retained in the threonine product. This small amount of 
mechanistic Information allows the following mechanism for the conversion of (2S)- 
O-phosphohomoserine (43) to (2S,3R)-threonine (44) (Scheme 1.29) to be 
proposed.
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OPO;
H (53)
Enz
H (54)
Enz
H (55)
ÇH3
« CH3
(57)
CH3 1
GO2 
NHg 
(44)
Scheme 1.29: The proposed mechanism of threonine synthase.
The conversion of the external aldimine (53) to the quinonoid intermediate (54) 
increases the acidity of the 3-pro-S proton of the substrate such that the p,y- 
elimination of phosphoric acid can occur. If threonine synthase shows the same 
stereochemical imperative as other PLP-dependent enzymes in utilising the 4 ’-s/- 
face of the coenzyme for its reactions the elimination would occur in a sy/i-fashion 
to give the conjugated enamine (55). Protonation at C-4 of the imino acid moiety of
(56) would allow attack by water at C-3 on the 4 ’-s/-face of the coenzyme to give 
product quinonoid (57). Protonation at 0 -2  would then furnish the product 
aldimine, which upon transaldimination would yield (2S,3R)-threonine (44 ).
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The p,Y-elimination of phosphoric acid may happen in a sequential or concerted 
manner. It has also been postulated that if this elimination does occur in a 
concerted manner, then the phosphate may act as the base removing the C-3 
p r o t o n . T h i s  would give a plausible six-membered intermediate.
O H U
There are many questions that arise from this postulated mode of action, and these 
will be considered in the discussion.
The Inhibition of Threonine Synthase.
Compounds that can block the action of threonine synthase may be of herbicidal, 
bactericidal or fungicidal potential. These compounds may also be able to yield 
mechanistic information about the enzyme. Some amino acids inhibit threonine 
synthase as part of the control of enzyme activity. Cysteine shows strong inhibition 
of TS from soybean,^® sugar beet®^ and Brevibacterium fiavum'?^ but no inhibition 
of TS from other sources such as b a r l e y ^ a n d  Lemna.^^ Methionine shows 
inhibitory effects for the barley e n z y m e , w h i l s t  glutathione inhibits in 
Brevibacterium flavum.^^ Other natural amino acid inhibitors are listed in Table 
1.30.
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Beet Barley Lemna Soy bean Brev. flavum
cysteine V X X V
methionine - V - - -
glutathione - - - - V
alanine - - - " V
threonine - - - - V
isoleucine - - - - V
lysine - - - V
phosphothreonine - - V - -
phosphoserine - - V - -
Table 1.30: The inhibition of threonine synthase from various sources by
naturally occuring amino acids.
It has been reported that AMP is a potent and stucturally specific competitive 
inhibitor of threonine synthase of Lemna.^^^ Phosphate is also an inhibitor of the 
enzyme in Lemna, but this has not been reported for any other source of the 
enzyme Interestingly threonine synthase from Lemna does not seem to be 
inhibited by propargylglycine (34) or gabaculine (38). Furthermore vinylglycine 
(31) inhibits the Lemna enzyme only very weakly.
The plumbemycins (58)^^^'^^^ and rhizocticins (59)"*®  ^ are di- and tripeptides that 
possess bactericidal, fungicidal or acaricidal activity depending on the nature of the 
peptide.
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NH
NH
COpHCOpH
(58)
R = COpH, CONH
(59)
R = H, Val, lie, Leu
(2S)-Z-2-Amino-5-phosphonopent-3-enoic acid, or Z-APPA (60), is the active 
component of these two groups of polypeptides. This compound has been shown 
to decrease the activity of threonine synthase by acting as a suicide inhibitor."*®® It 
has also been reported as having herbicidal activity.
NHg 0
H .J "
HOgC ----- OH
(60)
Recently the synthesis and investigation of novel inhibitors of threonine synthase 
has been attracting considerable a t t e n t i o n . T h e  inhibitors depicted below 
are effective (Figure 1.31).
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H2 N r -  OPO3 2 - 
\
OH
Ki = 6.3ixM
H"”y  V'“H
02C
"02C
" O H
Kj = 31 |xM
H ^ O H
" "o h
Kj = 0.1 |iM
SO g C ^ —  ^  'O H
Kj “  194}xM
"o h
Kj = 225|xM
NH2  o o
OH
Kj = 330|xM
H . r ^ X0 2 C ^ ^ '^ ^ 0 "  OH 
Kj = 50jiM
" O H
Ki = 10|xM
OH
Kj = 57jo,M
O2C ".O H
Kj = 4 0 0 |l iM
Kj = 540|a,M
Figure 1.31: Some inhibitors of threonine synthase.
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DISCUSSION
2 Introduction.
As already mentioned (section 1.4) there is considerable interest in the structure 
and mechanism of threonine synthase.®^ Such Information is needed to underpin 
the rational design of potential inhibitors of the enzyme, which may be useful as 
herbicides, fungicides or bactericides. In general terms, specific inhibitors would 
be of particular importance to the agrochemical industry where targeting an 
enzyme that only occurs in bacterial and plant biosynthetic pathways is highly 
desirable. Clearly, inhibitors of this type may cause no adverse affects on animal 
species, and, therefore, potentially represent a strategy for minimal environmental 
impact. Furthermore, and specifically, it is known that blocking amino acid 
biosynthesis is a highly effective method of inhibiting growth in plants and 
bacteria.
Although there is much literature on the sequence and mechanisms of control of 
threonine synthase, details of its mode of action remain sparse. In order to obtain 
as much information as possible about the kinetics and mechanism of the enzyme, 
it was important to first find a suitable source of the enzyme, and method for its 
purification. It was also important to develop an efficient and convenient synthesis 
of the substrate (2S)-0-phosphohomoserine (43), which would be flexible enough 
to allow for the synthesis of anologues and isotopomers.
The Postulated Mechanism of Threonine Synthase.
In spite of the fact that there was only a small amount of information available in the 
literature on the mechanism of the threonine synthase system, by drawing 
analogies to other PLP dependent enzymes it was possible to suggest the
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mechanism shown in Scheme 2.00 (see also section 1.4). The mechanism 
provided a framework for our thinking and the design of all of the experiments 
described in this thesis.
After the substrate binds to holoenzyme, transaldimination occurs to give the 
external aldimine (53). It is believed that the conversion of the external aldimine 
(53) to the quinonoid intermediate (54) increases the acidity of the C-3 protons of 
the substrate by creating an allylic environment. Thus the p,y-elimination of 
phosphoric acid can occur to give the conjugated enamine (55).^®’"*®® It is known 
that in yeast the 3-pro-S proton is removed in this step, as shown in Scheme 2 .00 . 
Proto nation at 0 -4  of the imino acid moiety of (55) would give the enimine (56). 
Attack by water at 0 -3  of the enimine (56) would then give the product quinonoid
(57). Protonation at 0 -2  of the quinonoid (57) would then furnish the product 
aldimine, which upon transaldimination would yield (2S,3A)-threonine (44).
This mechanism, although plausible, still leaves many questions to be answered:
i) How kinetically important to the overall mechanism is the removal of the 0 “ - 
proton to give the quinonoid intermediate (54)? In other words, is it kinetically 
more difficult to remove the 0®-H atom than the 0-3 proton?
ii) In the E. coli enzyme, is it the 3-pro-S proton that is removed? When Fuganti 
determined the stereochemistry of this step he used the yeast enzyme,^®® and 
although one would expect the stereochemistry to be the same in this case, this 
cannot be assumed. Yeast is a eukaryotic organism, and has a far more complex 
metabolic system than prokaryotes such as E. coli.
iii) The removal of the 0 -3  proton and the elimination of phosphate from the 
quinonoid intermediate (54) may be sequential or concerted. If the enzyme does
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indeed show the same stereochemical imperative as other PLP dependent 
enzymes in utilising the 4'-s/-face, then the elimination would occur in a syn  
fashion to give conjugated enamine (55), as shown in Scheme 2.00. it has also 
been postulated that if this elimination does occur in a concerted manner, then the 
phosphate may act as the base removing the C-3 proton.
It is also possible that the proton may be abstracted by the e-amino group of the 
transaldiminated lysine residue. Also, we do not know which face of the coenzyme 
the phosphate leaves from.
iv) Does reprotonation of the enamine (55) to give the imino acid moiety (56) occur 
with retention of configuration, and which side of the coenzyme does the 
protonation occur from? Is this step reversible? Is the proton attacking at 0 -4  
derived from the same base that removed the 0-3  proton, i.e. is there internal 
proton transfer when the substrate is converted to product?
v) The attack of water at 0-3  of (56) is defined by the stereochemistry of 0 -3  of 
threonine (that is 3H), but the geometry of the attack is not known with respect to the 
coenzyme. The water molecule could attack from either the 4'-s/- or 4'-re-face of 
the coenzyme.
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H +NH:EnzCOp
CO2LysNH.
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CH CM;
H (53) H (54)
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mb' :0H2
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HOCO2CO2
CH OH;N OH; 
H (55) (56) H (57)
OH;
HO... r.co2NH CH
HO.,
,PO'
NH;
(44)
Scheme 2.00: The postulated mechanism of threonine synthase.
From the mechanism outlined above it was evident that we needed to develop a 
synthesis for the substrate (2S)-0-phosphohomoserine (43) which be amenable to 
isotopic substitution at various positions on the substrate. For instance, by labelling 
phosphohomoserine with deuterium or tritium it may be possible to address the
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questions raised earlier in points I), ii) and iii).
In designing the best route for the synthesis of the substrate (2 S ) -0 -  
phosphohomoserine (43), it was important to keep in mind the questions we would 
like to answer. The investigation of point i) the kinetic importance of C^-H removal 
could be addressed by the inclusion of a deuterium atom in this position, allowing 
the measurement of the primary deuterium isotope effect. The confirmation of 
Fuganti's finding's"*®  ^ regarding the stereochemistry of C-3 proton removal (point ii) 
could be investigated by the stereospecific labelling of phosphohomoserine at 
each of the C-3 positions. If the isotope incorporated into the substrate was 
deuterium this would facilitate the assessment of the kinetic importance of this step, 
also by measurement of the kinetic isotope effect. If we wanted to alter the 
substrate in these ways, it would be necessary that the synthesis was amenable to 
this.
If the transfer of the deuterium from the C-3 position to the C-4 position was 
examined by fH-NMR spectroscopy, it would be possible to comment on whether 
the same base was responsible for reprotonation of C-4 (point iv). Flavin and 
Slaughter saw no internal proton transfer of this sort, when they assessed tritium 
transfer from the substrate to the p r o d u c t . H o w e v e r  if the base-bound proton is 
readily exchangeable with solvent protons, then only a very small amount may be 
transferred, and careful analysis of the isotope content of the threonine methyl 
group from very short-time experiments would be required
The synthesis of phosphohomoserine analogues stereospecifically altered at each 
of the C-4 positions, would allow us to deduce the geometry of the reaction at C-4. 
For example, (2S ,4S)- and (2S,4f?)-methyl-0-phosphohomoserine could be 
synthesised. If either diastereomer was a substrate, then we may be able to infer 
the geometry of the active site with respect to C-4.
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It was decided to commence our studies by first tackling the stereochemistry of the 
C-3 proton removal and its kinetic importance to the overall mechanism, together 
with the importance of the C“-H removal. This, we decided, would be possible by 
measuring the primary deuterium isotope effects for the turnover of deuterium 
labelled (2S)-0-phosphohomoserine isotopomers.
A rough alignment of threonine synthase from E. colP^ and yeast®^ was carried out 
to ascertain the similarity of the two proteins' sequence (Figure 2.01). If the 
sequence was very similar, especially close to the active site, then there would be 
no reason for the stereochemistry of the mode of action of these enzymes to be 
dissimilar. As we can see from Figure 2.01, there is a fair degree of homology 
around the active site, but there appears to be very little similarity in the outlying 
sequence.
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1 10 20 30 40 50 60
MPNASQVYRSTRSSSPKTISFEEAIIQGLATDGGLFIPPTIPQVDQATLFNDWSKLSFQDLAFA
MKLYNLKDHNEQVSFAQAVTQGLGKNQGLFFPHDLPEFSLTEIDEML
70 80 90 100 110 120
IMRLYIAQEEIPDADLKDLIKRSYSTFRSDEVTPLVQNVTGDKENLHILELFHGPTYAFKDVAL* * * * * * * * * * *  * * *  *
KLDFVTRSAKILSEFIGDEIPQEILEERVRAAFHFPAPVANVESDVGCLELFHGPTLAFKDFGG
130 140 150 160 170 ISO 190
QFVGNLFEYFLQRTNANLPEGEKKQITWGATSGDTGSAAIYGLRGKKDVSVFILYPTGRISPI
RFMAQMLTHIAGDKPVTILTATSGDTGAAVAHAFYGLPNVKWILYPRGKISPLQEKLFCTLGN
200 210 220 230 240 250
QEEQMTTVPDENVQTLSVTGTFDNCQDIVKAIFGDKEFNSKHIWGAVNSINWARILAQMTYYF 
*  *  *  *  *
lETVAIDGDFDACQALVKQAFDDEELKVALGLNSANSINISRLLAQICYYFGAVAQLPQETRNQ
260 270 280 290 300 310 320
YSFFQATNGKDSKKVKFWPSGNFGDILAGYFAKKMLGLPIEKLAIATNENDILISSNFERLLW  
*  *  *
LWSVPPSGNFGDLTAGLLAKSLGLPVKRFIAATNVNDTVPRFLHDGQWSPKATQATLSNAMDV
330 340 350 360 370 380
YLAREYLANGDDLKAGEIVmWFQELKTNGKFQVDKSIIEGASKDFTSERVSNEETSETIKKIY
SQPNÎWPRVEELFRRLIWQLKELGYAAVDDETTQQTMRELKELGYTSEPHAAVAYRALRDQLNP
390 400 410 420 430 440
ESSVNPKHYILDPHTAVGGVCATERLIAKDNDKSIQYISLTAHPAKFADAVTSfNALSGFSNYSFE
GEYGLFLGTAHPAKFKESVEAILGETIDLPKELAERADLPLLSHNLPADFAALRKLMMNHQ
450 460 470 480 490
KDVLPEELKKLSTLKKKLKFIERADVELVKNAIEEELAKMKL
Figure 2.01 : Sequence alignment of threonine synthase from yeast (top) and
E. coli (bottom). Numbering is with respect to the yeast sequence. 
Stars indicate conserved residues. The lysine residue at 124 
emphasised in bold is involved in transaldimination.
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Introduction to Kinetic isotope Effects.
One of the most informative ways to study enzymes and their mechanisms is by 
looking at their kinetic p r o p e r t i e s W h e n  coupled to the study and comparison 
of isotopically labelled substrate, a very much more detailed understanding of the 
system can be gained. Indeed, isotope effects provide a powerful tool for 
determining kinetic mechanisms and kinetically rate limiting steps, even in complex 
mechanisms.''®^
Isotope effects occur when an isotope (normally a heavier isotope) is substituted for 
an abundant isotope in a substrate. For example, one may substitute deuterium or 
tritium for protium, for "'^C, "'®N for or for ^®0. A substitution of this 
sort may alter the equilibrium constant for the reaction (an equilibrium isotope 
effect), or the rate constants for one or more steps in the reaction (a kinetic isotope 
effect). Isotope effects are referred to as primary when bonds are made or broken 
to the isotopic atom during the reaction; and secondary when they are not.
In simple terms, an isotope effect arises because the vibrational frequencies of the 
isotopic atom are different in the product and/ or in the transition state, to their 
vibrational frequencies in the substrate. For example, in a reaction where a C-H or 
a bond is broken in the transition state, more energy is required to bring the 
C-^H bond to the transition state from the ground state than for the lighter C-H bond 
system.''^® Therefore an isotope effect for the reaction can be measured by 
comparing the kinetic properties of the labelled and unlabelled compound. Exactly 
the same reasoning holds for enzyme catalysed reactions but here binding and 
debinding steps can suppress isotope effects.
In view of the fact that we wished to examine the cleavage of C-H bonds, it was first 
necessary to label the substrate with deuterium in the C“ -, 3-pro-S and 3-pro-R
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positions. Accordingly, syntheses of (2S,3f?)-[3-^Hi]-, and (2S,3S)-[3-^Hi]- and 
(2S)-[2-^Hi]-0-phosphohomoserine: (43a), (43b) and (43c) respectively, were 
devised.
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2.1 Synthesis of (2 S )-0 -P h o s p h o h o m o s e rln e .
Several approaches to the synthesis of (2S)-0-phosphohomoserine (43) are 
reported in the literature. 79,85,171-174
Agren reported the isolation of phosphohomoserine from trichloroacetic acid 
extracts of Lactobacillus easel. A yield of 55 mg of the substrate was obtained from 
650 g (dry weight) of c e l l s . " ' A  few years later, Watanabe and co-workers 
reported the synthesis of phosphohomoserine by the treatment of homoserine with 
a yeast preparation containing homoserine kinase."'^®
Ten years later. In 1973, Fickel and Gilvarg reported the first synthesis of 
phosphohomoserine starting from (2S)-homoserine (49) in 17% yield (Scheme 
2 .0 2 )." '^ 2  /V-Protection with f-butoxycarbonylazide to yield the N -t-  
butoxycarbonylhomoserine (61) followed by estérification with benzyl 3-p- 
tolytriazene gave a-benzyl-A/-f-butoxycarbonylhomoserine (62). Phosphorylation 
with diphenylchlorophosphate, and removal of the butoxycarbonyl and benzyl 
protecting groups with boron trifluoride and hydrogenolysis respectively afforded 
phosphohomoserine (43). The authors reported that almost 20% racémisation had 
occurred in the final product.
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NH2 
(49)
OH (i)
XO NH
HO2C
(61)
OH
BOC,NH
PhCH2CO20
(62)
(V)
OH
BOG,NH .
M  ^ 9  OH
PhCH2C02C ^ ^ 'O H
(63)
(43)
Reagents: (i) f-butoxycarbonylazide; (ii) benzyl-3-p-tolytriazene; 
(ill) diphenylchlorophosphate; (iv) BP3 (OEt2); (v) H2 , Pd/ 0.
Scheme 2.02: Fickel and Gilvarg’s synthesis of (2S)-0-phosphohomoserine.
Schnyder and Rottenburg reported a more efficient synthesis two years later 
starting from a-p-nitrobenzyl-N-benzyloxycarbonyl-(2S)-hom oserine (6 4 ) J ^4 
Phosphorylation again with diphenylchlorophosphate, followed by hydrogenolysis 
gave the desired (2S)-0-phosphohomoserine (43) in 62% yield.
1 7
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Skarstedt and Greer have used purified aspartokinase to phosphorylate (2S)- 
homoserine (49) at the expense of ATP in 90% yield.®® The enzyme was purified 
from a threonine synthase deficient strain of Bacillus subtilis, and the authors 
reported that the product, after purification by ion exchange chromatography, was 
completely free of phosphate containing contaminants.
A synthesis of phosphohomoserine labelled at the each of the 0 -3  positions with 
either tritium or deuterium had already been carried out by Fuganti's group 
(Scheme 2.03).'*^® Addition of hydroxylamine in ethanol to E-[a-^Hi]-cinnam ic  
acid (65) yielded a racemic mixture of 3-amino-3-phenyl-[2-^Hi]-propionic acid 
(66). After resolution the propionic acids (66) were reduced in boiling dioxan with 
LiAIH4 to give the corresponding alcohols (67). Ozonolysis of the alcohols 
followed by oxidative work-up and acid hydrolysis gave the corresponding labelled 
(2S)-homoserine (49). The preparation of C-4 labelled racemic homoserine in an 
analogous manner was also described. However no yields are quoted in the 
communication, and despite comprehensive searching of the literature, no full 
paper could be located.
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(65)
COgH COgH
(66)
NH,
III
HOgC gT OH'H 
(49)
Reagents: i) NHgOH, EtOH; ii) LiAIH^, dioxane;
iii) acétylation, ozonolysis, reductive work-up.
Scheme 2.03: Fuganti’s synthesis of iabelled homoserine.
All of the above methods were judged to be too lengthy or impractical for our 
needs. We would require substantial quantities of the substrate and its labelled 
isotopom ers ( {2 S ,3 R )- [3 -2 h  i] - , (2 S ,3 S )- [3 -2 h  i ] -  and (2 S )- [2 -2 h  i ] - 0 -  
phosphohomoserine) to allow us to determine the stereochemistry and kinetic 
importance of cP-proton abstraction from the substrate, and the relative importance 
of C“-H abstraction in the mechanism of threonine synthase.
As it was already possible, using a well established method developed previously 
in our laboratories, to incorporate deuterium selectively into the 3-pro-R and 3-pro- 
S and C“ -positions of (2S)-aspartic acid (45),^^^"^^^ we decided to utilise this as 
our starting material. Hence a route for the conversion of (2S)-aspartic acid to 
phosphohomoserine would allow the introduction of a deuterium atom at any of the 
proton sites on the molecule. This would constitute a biomimetic synthesis.
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Dimethyl acetylenedicarboxylate (68) was reacted with triphenylphosphine in 
deuterium oxide to yield dimethyl dideuteriofumarate (69) as a dark red tar in 
moderate yield (Scheme 2.04) according to the method of Richards et 
Removal of triphenylphosphine oxide by sublimation gave the dideuteriofumarate 
(69) as a pale yellow solid which was recrystallised from methanol to give the pure 
product. The '•H-NMR spectrum showed only one signal at 3.81 ppm due to the 
methyl esters. By scrupulously ensuring that water was excluded from the reaction, 
the deuterium incorporation into the product was judged to be greater than 97% (as 
judged by ^H-NMR and mass spectroscopy). Saponification readily converted the 
diester into the free dideuteriofumaric acid (70) in good yield .
(68) (69) (70)
Reagents: (i) PhgP, ^HgO. THF; (ii) 12% NaOH.
Scheme 2.04: The synthesis of dideuteriofumaric acid (70).
Dideuteriofumaric acid (70) was converted in a trans  manner to (2 S ,3 S )-  
[2-^H 1,3-^H 1 ]-aspartic acid (45a) according to a modification of the method of Gani 
and Y o u n g ,"(77 published by Akhtar et al. using the enzyme p-methylaspartase in 
60% yield (Scheme 2 .05).^78 jj^jg compound showed only one signal at 2.51 ppm 
in the ‘•H-NMR spectrum, corresponding to the CP-H atom. Further reaction with 
PLP dependent aspartate aminotransferase gave the desired (2S ,3S )-[3 -2H ij- 
aspartic acid (45b), as illustrated by the appearance of the C“-H atom at 3.50 ppm. 
This enzyme is known to catalyse the reversible exchange of the C-2 hydrogen of 
aspartic acid with solvent hydrogen. 7^9
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(2S,3f?)-[3-2Hi] Aspartic acid (45c) was synthesised by incubating fumaric acid 
(70a) with p-methylaspartase in deuterium oxide (Scheme 2.05) {m/z Found: M+, 
135.0498, C4H6^HN0 4  requires 135.0516). (2S)-[2-2Hi]-Aspartic acid (45d) was 
prepared via deuterium oxide exchange with the C'^-proton of (2S)-aspartic acid 
using a commercial preparation of aspartate aminotransferase (Scheme 2.05).
HOgC 2|_| HO2O H "  HO2C H
(70) (45a) (45b)
Hv^COaH (III) HaN CO2H
(70a) (45c)
H2N CO2H  ^ H2N CO2H
HO2C HO2C H "
(45) (45d)
Reagents: (i) p-methylaspartase, NH3 , K+, H2O; (ii) AAT, PLP, H2O;
(iii) p-methylaspartase, NH3 , K^ , Mg^+, ^H2 0 ;
(iv) AAT, PLP, ^HgO.
Scheme 2.05: The synthesis of deuterium labelled isotopomers of (2S)-aspartic 
acid.
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It was envisaged that the most direct route for the synthesis of phosphohomoserine 
(43) would be a simple phosphorylation of a protected homoserine derivative 
prepared by reducing the |3-carboxyl group of aspartic acid (Scheme 2.06). It 
would be neccessary to protect the amine functionality of aspartic acid before 
carrying out this procedure. The a-carboxyl group would also have to be 
selectively protected.
H‘"Jns^ C02H
Scheme 2.06: The strategy of the synthesis of (2S)-0-phosphohomoserine (43).
Butoxycarbonyl protection of aspartic acid was unsuccessful under a variety of 
conditions. Benzyloxycarbonyl (Z) protection using benzyl chioreformate and 
sodium hydroxide under Schotten-Baumann conditions only resulted in 50%  
isolation of the product.’’®^  Carrying out the Z-protection under Bergmann and 
Zervas' conditions where (2S)-aspartic acid (45) is suspended in water with 3 
equivalents of magnesium oxide, followed by the addition of benzyl chloroformate; 
resulted in the formation of A/-carbobenzyloxy (2S)-aspartic acid (71) in a 62%
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yield after r e c r y s t a l l i s a t i o n / T h e  product (71) was treated with trifluoroacetic 
anhydride in tetrahydrofuran to give the Z-protected cyclic anhydride (72) in 
excellent yield. Selective opening of the cyclic anhydride was attempted using a 
variety of alcohols, including isopropanol, p-nitrophenol, and 2,4-dinitrophenol. 
Alcoholysis with isopropanol gave the best selectivity, and a-isopropyl Z-aspartic 
acid (73) was isolated in 55% yield (Scheme 2.07).
(i)H-Js^COgH .........
HO2C H - ;^ C 0 2 HHO2C
(45) (71)
0 ^ 0
H -4 s^ C 0 2 H
(72) (73)
Reagents: (i) MgO, PhCHgOCOCI, H2O; (ii) TFAA, THF; (iii) 'PrOH.
Scheme 2.07: The formation of a-isopropyi N-carbobenzyloxy (2S)-aspartic 
acid (73).
As the desired p-free acid (73) was only obtained in moderate yield, we decided to 
investigate the use of the trifluoracetyl N-protecting group in order to improve the 
overall yield of the synthesis. This would have the advantage of both N-protection 
and formation of the protected cyclic anhydride in a one pot reaction (Scheme 
2.08) using the procedure described by Gani and Y o u n g . ( 2 S ) - A s p a r t i c  acid 
was therefore treated with 5 equivalents of trifluoracetic anhydride in anhydrous 
THF with cooling. The reaction mixture became homogeneous over a period of
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around 2 h. Removal of the solvent and careful removal of excess trifluoracetic 
acid under vacuum allowed the isolation of N-trifluoracetyl (2S)-aspartie anhydride 
(74) as a white solid in excellent yield (vmax Nujol/ cm"  ^ 1805 (C =0) and 1685 
(C=0)). Although it was possible to recrystallise the cyclic anhydride from dry ether 
and petroleum ether, the hygroscopic nature of the compound meant that it was 
more efficient to take the anhydride through to the next step without further 
purification.
The selective protection of the a-carboxyl group through treatment of the anhydride 
with methanol had been described in the past and was reported to yield 75-80% of 
the desired a-methyl ester p-acid.^®^ The remainder was the unwanted a-acid  
p-ester. Performing the reaction at temperatures down to -78 °C did not improve 
the ratio in favour of the a-ester, nor did treatment with ethanol. However, 
treatment of the anhydride with isopropanol at 0 °C gave the desired a-isopropyl 
ester p-acid (75) in 92% yield after one recrystallisation from ether and petroleum 
ether (Found: C, 39.90; H, 4.65: N, 5.25. C9H12NO5F3 requires C, 39.90; H 4.45; 
N, 5.15%).^®^ Examination of the C-3 proton signals in the iH -NM R spectrum of 
the crude material (before purification) indicated that the regioselectivity of attack at 
the a-carbonyl group was better than 25:1. The highly selective nature of this 
reaction is thought to be facilitated by the electron withdrawing effect of the 
A/-trifluoracetyl protection, which enhances the electrophilicity of the a-carboxyl 
carbon.
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HO2C 
(45) (74) (75)
Reagents: (i)TFA, THF; (ii)'PrOH.
Scheme 2.08: The formation of a-isopropyi N-trifluoracetyl (2S)-aspartic acid.
Having protected the a-carboxylic acid as the isopropyl ester (75), a range of 
methods and conditions for reducing the p-carboxyl group to the corresponding 
alcohol were examined. The reduction of the free p-carboxylic acid group was not 
a trivial problem. The use of LIAIH^ was precluded due to the protecting groups 
already in place. It is always necessary to activate carboxylic acids before 
reduction to an alcohol by borohydride. Reduction of the the p-carboxyl group was 
attempted by first forming the mixed p-asparlic isobutylcarbonic anhydride from the 
acid (75 ) by treatment with an equivalent of A/-methyl morpholine and 
isobutylchloroformate at -40 °C, following the reaction by tic. After removal of the 
precipitated salts, the mixed anhydride was treated with a solution of aqueous 
sodium borohydride. This procedure was found to be unsuccessful and none of 
the required alcohol was formed. The amount of borohydride used in the reduction 
was varied; however this did not improve the situation. Changing the solvent used 
for the reduction allowed the isolation of some of the desired alcohol product. After 
several further trial experiments in THF, isopropanol and DOM, it was found that 
carrying out the reaction in anhydrous TH F yielded the desired 
A/-trif!uoroacetylhomoserine isopropyl ester (76) in excellent yield (Scheme 2.09). 
Ishizuma and coworkers describe a similar procedure using ethyl chloroformate to
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form the mixed a n h y d r i d e . P u r i f i c a t i o n  of the alcohol by flash silica 
chromatography eluting with diethyl ether/ petroleum ether/ ethyl acetate (2:4:4) 
containing a small amount of acetic acid gave a-isopropyl N -trifluoracetyl 
(2 S)-homoserine (76) as a pale yellow oil in yields of up to 93%. The ‘•^C-NMR  
spectrum clearly showing the loss of the carbonyl signal at 175.9 ppm, and the 
appearance of a new signal at 59.2 ppm corresponding to the CH2OH. Note that 
an ideal tic visualisation stain for the protected (2S)-homoserine was not found 
during the course of this work. Nevertheless, a dilute solution of potassium 
permanganate allowed the visualisation of the compound.
Base catalysed hydrolysis of the trifluoroacetyl and iso propyl protecting groups of 
alcohol (76) in aqueous ethanol afforded (2 S)-homoserine (49) in 95% yield, 
representing an overall yield of 85% from (2S)-aspartic acid (45) after ion- 
exchange chromatography (Scheme 2.9). This compares well with other 
syntheses from aspartic acid. 1^5 No loss of chiral integrity occurred at C-2 during 
the saponification {[a]o -24.4 (c 10 in water) and lit.,^^^ [a]o -24.5 (c 10 in water)} 
and the sample was in all respects identical to an authentic sample.
OUFgC^NH
(75)
(I), (ii) .
XFgC'^NH H ■•'!
O OH
(76)
NH2
HO2C OH
(49)
Reagents: (i) NMM,'BuOCOCI, THF; (Ii) NaBH4 , THF; (lll)IMKOH.
Scheme 2.09: The synthesis of (2S)-homoserine (49).
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In order to convert the alcohol (76) into its phosphate ester derivative, a range of 
phosphorylating reagents were considered. As phosphate esters are labile under 
acidic conditions, we chose to form a phosphate ester in which the protecting 
groups could be removed under basic or neutral conditions. We had already 
established that the N-trifluoroacetyl and isopropyl protection could be removed 
under alkaline conditions without loss of chiral integrity and, therefore, opted first to 
form the base-labile b/scyanoethyl phosphate triester (77) which should cleave via 
^-elimination to give the phosphate moiety.
Accordingly, the alcohol (76) was treated with A/,A/-diisopropyl b/scyanoethyl 
phosphoramidite (78) to give the phosphate triester which was oxidised in situ 
using m-CPBA in dichloromethane. The phosphoramidite reagent (78) has been 
previously used to phosphitylate the primary 5'-hydroxyl group of 
oligonucleotides’^ ®® and the primary 6-hydroxyl group of carbohydrates.^®^ The 
phosphoramidite (78) was readily prepared in two steps from phosphorus 
trichloride (79)  (Scheme 2.10).^®® The addition of two equivalents of 
diisopropylamine to phosphorus trichloride in diethyl ether afforded the 
N ,N -diisopropyldichlorophosphoram idite (80)  in moderate yield (60%). 
Estérification via  nucleophilic displacement of chloride with excess 
3-hydroxypropionitrile in the presence of triethylamine yielded the phosphoramidite 
(78), which could be purified by silica gel column chromatography in 61% yield 
(m/z Found: M+, 271.1462. C12H22N3O2P requires 271.1460).
73
Ck^xCI
Reagents: (i) ('POgNH, EtgO; (ii) 3-hydroxypropionitrile, EtgN.
Scheme 2.10: The synthesis of N,N-diisopropyl biscyanoethylphosphoramidite.
The addition of 1.5 equivalents of the phosphoramidite (78) to the protected 
homoserine (76), in the presence of tetrazole, resulted in an almost quantitative 
yield of the phosphite triester. Removal of the solvent followed by ^ H- NM R  
spectroscopy confirmed the phosphitylation had been successful. The phosphite 
was treated without further purification with 1.5 equivalents of m-CPBA in DCM as 
described by Corrie and Trentham.^®® The resulting phosphate triester (77) was 
obtained in excellent yield (87%) but proved difficult to purify. The ^®C-NIVIR 
spectrum clearly showed phosphorus splitting of the signals. {Ôc (50.3 MHz; 
C^HCIa) 20.0 (d, J7 .3 , POC), 22.1 (frC H s), 32.2 (d, Jrc 5.3, CP), 50.1 (C«), 63.4 (t, 
J5.1,  -^CN), 65.0 (d, Jpc 5.8, C'Y), 71.2 (frC H ), 116 (q, Jrc 290, F3C), 117.2 (ON), 
158.2 (q, J fc  38, F3CC.O) and 170.3 (COa'Pr).} Attempts to deprotect the crude 
material directly under a variety of basic conditions met with limited success. 
Although (2S)-0-phosphohomoserine (43) could be purified from the hyd rosy late 
by ion-exchange chromatography, it was evident that much of the product was 
(2 S)-homoserine (49). Most of the phosphate group had been hydrolysed under 
the reaction conditions, and the pseudoquartet signal provided by phosphate 
splitting of the y-hydrogens was absent. Using diphenylphosphorochloridate as 
phosphorylating agent did not improve the retention of the phosphate group.
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In order to prevent the hydrolysis of the phosphate moiety by base, we opted to use 
benzyl protecting groups for the phosphate triester and to carry out the deprotection 
in two stages. The phosphoramidite (81) was synthesised in a similar manner to 
that described for ( 7 8 )  above,  using benzyl alcohol instead of 
3-hydroxypropionitrile in 72% yield {m/z, Found: [M + H]+, 346.1936. C20H29NO2P 
requires 346.1936). Thus, the alcohol (76) was treated with A/, A/-di iso propyl 
dibenzyl phosphoramidite (81) and the intermediate phosphite was oxidised with 
m-CPBA as described by Yu and c o w o r k e r s . T h i s  phosphorylation reaction 
proved to be very effective after optimisation of the reaction conditions. Using only 
one equivalent of phosphoramidite resulted in the phosphate triester (82) being 
obtained in 92% yield {m/z, Found: [M + H]+ 518.1556. C23H27NO 7PF3 requires 
518.1555).
N -K
(81)
The dibenzyl triester was then smoothly converted in two steps, via catalytic 
hydrogenolysis and then base catalysed hydrolysis of the protecting groups, to 
(2S)-0-phosphohomoserine (43) Purification by cation-exchange chromatography 
(Dowex 50-W (H+) form) eluting with water gave the pure phosphohomoserine in
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90% yield over the two steps. (2S)-0-Phosphohomoserine obtained via this 
reaction strategy results in an overall yield of 66% from aspartic acid (45), Scheme 
2.11. m/z (Found: [M + H]+ 200.0329, C4H11NO6P requires 200.0324); m.p. 170 
“C; 8h (200 MHz, ^HgO) 4.12 ( IN,  dd, Jax 12.4, Jbx4.9 Hz, 2-H), 4.01 (2H, dt, Jrp  
5.49, J  5.7 Hz, 4 -H2) and 2.23 (2H, m, S-Hg): 8c (50.3 MHz, 2H2O) 186.2 (CO2H), 
64.3 (d, Jpc 4.9 Hz, 4-C), 56.3 (2-C) and 38.7 (d, Jpo 7.4 Hz, 3-C); 8p (121.5 MHz, 
2H2O) 0.5; [a]o + 4.19 (c2.4 in water) [a]o 4.21 (c2.4 in water)}.
H2N 
Hx
i'-HeHa
(45)
COgH I, II
9FgC'^NH
Hx;;'PrOgC CO2H Ha’  Hb 
(75)
III, IV
V, VI
■ y ^ O C H g P h
'PrOgC^ ^  ^"OCHgPh
VII, VIII
Ha Hb
(82)
XFaC'^NH
(76)
OH
T '  o  
H O a C ^ °  "'OH
(43)
Reagents and conditions: i) TFAA, THF, 0 °C, 3 h; ii) 'PrOH, 0 °C, 48 h; iii) NMM, 'BuOCOCI, THF, -40 ^ C, 15 min.; iv) NaBH4 , THF, -40 ^ C, 4 h; v) 'Pr2NP(OBn)2 ,1-Htetrazole, CH2CI2 , 20 '^C, 45 min.; vi) m-CPBA, DCM, 0 ^ 0; vii) Pd/C, Hg, MeOH, 20 X, 24 h.; viii) KOH, EtOH, 20 ^ 0, 3 h.
Scheme 2.11: The synthesis of phosphohomoserine (43) from aspartic acid.
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In order to prepare the chirally deutehated enantlomers (43a, = H, Hg= ^H),
(43b, Ha = 2H, Hb = H) and (43c, Hx = ^H, Ha = Hb = H); (2S,3R)-;  (2S ,3S )- 
[3-2Hi ]“ and (2S)-[2-2Hi]-aspartic acids were subjected to the same reaction 
sequence as the unlabelled material, as outlined in Scheme 2.11. Each of the 
chirally deute hated (2S)-0-phosphohomoserines was obtained in ~60 % overall 
yield from aspartic acid and showed the expected omissions in the ^H- NMR  
spectra. In each case, the signal corresponding to the deuterium atom was missing 
and other signals showed a corresponding simplification. The ^^C-NMR spectra 
showed a splitting for each carbon atom attached to a deuterium atom.
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2.2 An Assay for the Detection of Threonine Synthase Activity.
In order to carry out any meaningful studies on threonine synthase, it was important 
for us to develop an accurate and sensitive assay for the reaction catalysed by 
threonine synthase. In most purifications and kinetic studies to date, turnover of a 
radiolabelled substrate has been detected by scintillation counting, or the products 
determined by a colourimetric assay.®® A colourimetric assay was judged to be 
potentially the most user friendly technique.
For some time inorganic phosphate has been detected colourimetrically by the 
reduction of phosphomolybdate to molybdenum blue.^®  ^ Some basic dyes form a 
complex with phosphomolybdate, increasing the sensitivity of the r e a c t i o n . T h e  
most effective of these complexes is that of Malachite green in acidic solution. Itaya 
and Ui found that levels of phosphate as low as 0.05 jag/ ml could be detected 
using this reagent.”*®^
An improvement on this method was reported in 1979 by Lanzetta et They
found that they could detect nanomolar amounts of phosphate by monitoring the 
adsorption at 660 nm of a sample treated with Malachite-molybdate complex. 
When tested this technique proved reproducible and convenient. The reagent was 
simply prepared by the addition of ammonium molybdate to a solution of Malachite 
green in hydrochloric acid. After filtration the reagent could be stored in the dark for 
periods of up to one month.
Addition of a sample (100 pi) containing phosphate to Malachite reagent (900 pi) 
formed a green solution. After the colour had been allowed to develop for 20 min, 
the absorption in the visible spectrum at 660 nm was measured. A standard curve 
was set up by measuring the absorptions of known concentrations of phosphate in
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triplicate, and then plotting the absorption as a function of phosphate concentration. 
Over the range 0-200 mM, the relationship was linear. At very high concentrations 
of phosphate it was sometimes neccessary to increase the ratio of reagent to 
phosphate containing sample.
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2.3 The Purification of Threonine Synthase.
E. coli was deemed the most convenient source of the threonine synthase enzyme 
for our needs. It was neccessary to find a constitutive mutant for the enzyme, 
because, as explained in detail in the introduction, the enzyme is only expressed 
under certain conditions, see page 38. There were literature reports of just such a 
constitutive mutant: E. coii K12 strain Tir8 . Unfortunately this strain was not 
commercially available, and was therefore kindly donated to us by Prof. C, Parsot 
of the Institut Pasteur, Paris.
E. coli cells were grown on L-broth^®'  ^ in 6 I batches. Harvesting of the cells was 
carried out by centrifugation once the culture had achieved the optimum cell 
density (ODeeonm « 9) after approximately 17 h. The cells were efficiently lysed by 
sonication and the cell debris was removed by centrifugation. The nucleic acids 
were then precipitated. Streptomycin sulfate and protamine sulfate were both 
tested for their efficacy in this process, and it was decided to use streptomycin 
sulfate in view of its superior solubility.
The first step in the purification of the protein lysate was an ammonium sulfate 
fractionation. Parsot and his coworkers used a 40-60%  ammonium sulfate 
f r a c t i o n . S u i t a b i l i t y  of this cut for our use was tested by a series of trial 
fractionations. The 40-60% saturation fraction was indeed found to have most 
activity (Table 2 .12).
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% sulfate saturation relative activity
30-40 15%
40-60 100%
60-70 10%
70-80 5%
Table 2.12: Relative threonine synthase activity of varying ammonium sulfate 
cuts of E. coli lysate.
The next step in the purification was size exclusion chromatography. Threonine 
synthase from E. coli has a reported molecular weight of around 37 000 daltons.®^ 
It was decided, therefore, that a G150 Sephadex column would give a satisfactory 
separation. A column of 80 x 3 cm was used with a relatively slow flow rate of 30 
ml/ h. Fractions (15 ml) were collected from the column (Figure 2.13), and were 
assayed for threonine synthase activity, using the malachite assay described 
above. The active fractions were pooled and ultrafiltrated to around 3 ml. The 
protein content of the concentrated fractions was found to be around 50 mg/ ml 
when measured by the Bradford method,''®® and the activity was 2 800 nmoles 
min"'' mg"''. The size exclusion column had to be repacked befo/e each use to 
ensure optimum flow rates.
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Figure 2.13: G150 column trace showing threonine synthase activity, 
a.u. stands for arbitrary units.
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Although the activity of threonine synthase was high enough from the G 150 column 
to allow us to carry out initial kinetic studies, we were keen to purify the protein 
further. Ion-exchange chromatography was attempted with DEAE Sephacel and 
DEAE TSK 5PW FPLC, eluting with a KCI gradient. Unfortunately in both cases, no 
active protein was found. These attempts were repeated lowering the pH in an 
attempt to combat the protein sticking to the ion-exchange material very tightly and 
being careful to assay the unbound fractions. It quickly became clear that the 
protein was in some way deactivating on the column. The experiments were 
repeated, adding threonine to the buffer in an attempt to stabilise the protein's 
active site. Sadly, this did not help. SDS-PAGE was carried out on the fractions to 
try and detect threonine synthase. Protein of the correct molecular weight was 
present, and this fraction was concentrated 100 fold to around 1 ml by ultrafiltration. 
The protein was assayed and found to be Inactive.
We were beginning to suspect that the lack of phosphate in the buffer was causing 
the enzyme to inactivate in some way. Parsot had successfully purified the enzyme 
using the same DEAE medium, although the column was eluted with a phosphate 
buffer.®^ It was decided to repeat this work, although the column would have to be 
run "blind", that is the fractions could not be assayed directly from the column. 
Instead, protein peaks eluted from the column were pooled (Figure 2.14) and the 
buffer exchanged for HEPES using a squat Sephadex G25 column (7 cm x 2.5 cm).
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Figure 2.14: DEAE Sephacel column trace.
Each pooled, buffer exchanged fraction was assayed, and indeed activity was 
found in fraction 4. An SDS-PAGE was carried out on the fractions, and a protein 
of the correct molecular weight was indeed found in fraction 4. Fraction 4 had a 
protein content of 0.5 mg/ ml. Attempts to purify the protein further were abandoned 
due to pressures of time, and the very labour intensive protocol. All subsequent 
kinetic experiments were therefore carried out using threonine synthase from the 
G150 column.
The amount of background non-specific phosphatase activity associated with this 
preparation of threonine synthase was determined. Tics of small threonine 
synthase assays were run in a solvent that distinguished between threonine, 
homoserine and phosphohomoserine (butanol/ methyl ethyl ketone/ H2O/ NH3 
4:3:2:1). No homoserine was detected when the tics were developed with 
ninhydrin.
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By carrying out sequential dilutions of homoserine and threonine and detecting 
their presence with ninhydrin, we could see that each of the compounds had an 
approximately equal lower limit of detection using this technique. This lower limit of 
detection was in the region of 1-10 nanomolar. It was judged that the amount of 
non-specific phosphatase activity was much less than 5% of threonine synthase 
activity. This indicated that kinetic assays carried out would only be affected to a 
small extent by other phosphatase activities.
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2.4 Determination of Kinetic Parameters.
introduction
For an enzyme-substrate reaction, the substrate binds to the enzyme to form the 
complex ES. The reaction then occurs and ES breaks down to give enzyme and 
products. This can be written as shown below:
ki koE + S - ES ------^  E + P
At a particular time each of E, S, and ES are present at the concentrations of et - x, 
s and X respectively, where et is the total concentration of free enzyme.
The rate of change of the concentration of ES is dx/dt and can be written as
d2L= ki (et-x)s - k2X - ksx = kiets - (kis+k2S+k3)x (1 )
dt
If steady state conditions are assumed, i.e. that the concentration of ES remains 
constant, then dx/dt = 0. Equation (1 ) can then be solved for x, giving
kiets
X = (2)
k"! s+k2+k3
The rate of reaction of the enzyme is first order with respect to the concentration of 
ES. Hence we have that:-
rate, v = kax (3)
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Substituting equation (2) in equation (3) gives 
kakiets
V =
kis+k2+k3
kaets
s+(k2+ka)/ki
(4 )
If the enzyme is present in large quantities compared to the enzyme, then s «
constant and the enzyme is said to be saturated. The rate v, is then directly
proportional to et. We can then write
kas
kapp = --------------------  (5)
s+(k2+ka)/ki
where kapp is the apparent first order rate constant for the enzyme reaction.
Taking reciprocals of both sides of rate equation (4) yields
1 1 ka+ka
—  =   +   (6)V kaet kikaets
Equation (6) can be written in the more general form 
1 = 1  Km
—  —  + - —  (7)
V V Vs
where V=kaet and KM=(k2+ka)/ki. From equation (7) it can be seen that a plot of 
1/v against 1/s will result in a straight line graph that intercepts the x-axis at - 1/Km 
and the y-axis at 1/V. The slope of the line will be equal to Km/V. One drawback to 
this method is that points of small v and s become overemphasised.
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In the analysis of the enzyme-substrate reaction data the numerical values of the 
rate (v) and substrate concentration (s) were fitted to the Michaelis-Menten kinetics 
using the computer program Enzfitter,^®® which carries out a direct non-linear fit 
and so avoids the overemphasis of small values of v and s, thus yielding the 
parameters Km and kcat (kcat = Vmax/et).
The kinetic isotope effect is the ratio of the reaction rates for molecules containing 
the light and heavy atoms, i.e. kn/ko, and is written as ^k (using Northrop notation). 
An isotope effect can also be observed on the equilibrium constant for the reaction, 
giving an equilibrium isotope effect, written as ^Keq. Isotope effects can be 
measured on both V and V/K, i.e. one can examine the difference in rates (^V) and 
the ratio of the apparent first order rate constant (^(V/K)). Thus, V and V/K are 
separately measured for both the labelled and the unlabelled substrate and 
comparison of the results will directly provide the isotope effects on V and V/K. This 
is the only method to determine an isotope effect on V as well as V/K, and requires 
a high level of isotopic substitution.
The observed values of the isotope effects on '^(V/K) and ^V are given by:-
^ k  +  Of +  Cf^Kgq
^(V/K) =
DV
1 +  Cf +  Of
^k + Cvf + ^KeqCf 
1 +  Cvf +  Cf
In this equation "^ k is the intrinsic isotope effect in the forward direction, and *^Keq is 
the equilibrium isotope effect. The constants Cf and Cr are commitments to the 
reaction in forward and reverse directions. A commitment is a ratio of the rate
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constant for the isotopically sensitive step to a net rate constant that refers to the 
release of a particular species from the enzyme. For example, a high forward 
reaction commitment indicates that it is considerably easier for the reaction to carry 
on in the forward direction, than to go back through earlier steps in the mechanism. 
Finally, the constant Cvf in the equation for is, in fact, not a commitment, but a 
special constant found only in this equation.
The symmetry of the equation for °(V/K) means that dividing it by ^Keq produces 
the comparable equation in the reverse direction. In general terms, it can be seen 
from the above equations that the observed isotope effect for an enzyme-catalysed 
reaction will vary depending on the values for the forward and reverse 
commitments. Thus when the forward commitment is large, the isotope effect is 
supressed, and ^(V/K) will approach unity.
Kinetic Experiments.
The values of Km and Vmax were measured for the conversion of 
phosphohomoserine to threonine by threonine synthase both with and without the 
reported allosteric activator S-adenosy! methionine. Initial rates were obtained in 
triplicate for the release of phosphate at several concentrations of the substrate 
(2S)-0-phosphohom oserine (43) (20, 30, 50, 100, 200 and 500 |xM) without 
activator and in the presence of 0.4 mM SAM at 37 °C. The reactions were initiated 
by the addition of 0.5 mg of threonine synthase. The data collected were fitted 
using the computer program Enzfitter'*^® and are presented graphically.
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Figure 2.15: The effect of S-adenosyl methionine on the initial rate of threonine 
synthase. Data fitted by non-linear regression using Enzfitter.
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Figure 2.16: Double reciprocal plot with and without S-adenosyl methionine.
Theoretical data points are derived from the best fit curves shown in 
Figure 2.15
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Examination of the plots of initial rates (Figure 2.15) and their reciprocals (Figure 
2.16) shows that S-adenosyl methionine is clearly exercising some effect on 
threonine synthase. The Km for threonine synthase in the presence of the activator 
is almost doubled, and the Vmax has increased almost three-fold (Table 2.17). This 
is in accord with the results reported for threonine synthase from plants. Since 
in the presence of high concentrations of activators species binding and debinding 
processes can become the kinetically dominant steps, the kinetic isotope effects of 
the labelled isotopomers were conducted in the absence of SAM.
Km (pM) ±  error V m a x  (pMmin-1) ±  error
-SAM 43.5 7.62 4.18 0.22
+SAM 115.1 7.15 7.34 0.18
Table 2.17: The Vmax snd Km  for threonine synthase with and without SAM
The next experiment to be carried out was a comparison of the kinetic parameters 
of unlabelled phosphohomoserine with the (2S,3f?)-[3-^Hi]-isotopom er. If 
threonine synthase form E. ooli showed the same stereochemistry of C-3 proton 
removal as the yeast enzyme, then we would not expect to see a kinetic isotope 
effect for the labelled substrate. We can see both from the graphical portrayals 
of the rates (Figure 2.19 and 2.20), and from the kinetic parameters (Table 2.18) 
deduced from these that the substitution of (2S,3f?)-[3-^Hi]-0-phosphohomoserine 
for the unlabelled substrate has no effect within experimental error. has a value 
of 1.0 and ^(V/K) is 1.2.
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Km (|4M) ± error Vmax (|4M min-1) ± error
PHS 43.5 7.82 4.18 0.22
RPHS 52.1 8.56 4.09 0.22
Table 2.18: Kinetic data for (2S)-0-phosphohomoserine and (2S,3R)-[3-^Hi]-0- 
phosphohomoserine.
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Figure 2.19: A comparison of the initial rates of threonine synthase turnover of 
(2S)-0-phosphohomoserine and (2S,3R)-[3-^Hi]-0- 
phosphohomoserine. Data fitted by non-linear regression using 
Enzfitter
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Figure 2.20: The double reciprocal plot of threonine synthase activity with (2S)- 
0-phosphohomoserine and (2S,3R)-[3-^Hi]-0-phosphohomoserine. 
Theoretical data points are derived from the best fit curves shown in 
Figure 2.18.
When (2S ,3S )-[3 -^H i]- and (2S)-[2-^H i]-labelled phosphohomoserine were 
compared with the unlabelled substrate, significant changes in the kinetic 
parameters were observed (Table 2.21 and Figures 2.22 and 2.23).
Km (pM) ±  error Vmax (pMmin-1) ± error
PHS 43.5 7.62 4.18 0.22
SPHS 24.2 3.91 2.40 0.10
aPH S 35.69 4.79 3.50 0.14
Table 2 .21 : Kinetic data for (2S)-0-phosphohomoserine, (2S,3S)-[3-^Hi]-0- 
phosphohomoserine and (2S)-[2-^Hi]‘0-phosphohomoserine.
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We can see that the (2S,3S)-[3-^Hi]-isotopomer displays isotope effects of 1.74 
and 1.0 for and " (^V/K) respectively. This data reveals that the 3-pro-S hydrogen 
is removed from the substrate during the elimination process and is an identical 
result to that obtained for the yeast enzyme using tritiated substrates.^ 
Furthermore, the magnitude of the Vmax isotope effect indicates that the elimination 
process is slow compared to other steps in the catalysed reaction. The finding that 
the value of ^(V/K) is 1.0 shows that there are large forward reaction commitments 
and that the substrate cannot readily debind from the enzyme via reverse steps 
once the quinoid intermediate (55) has formed.
When (2S)-[2-^Hi]-0-phosphohomoserine was incubated with the enzyme and the 
rate data were processed, isotope effects of 1.2 and 1.0 were obtained for and 
■^(V/K) respectively. This result indicates that the removal of the C^-H from the 
substrate is kinetically significant but is not rate-limiting
5
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Figure 2.22: A comparison of the initial rates of threonine synthase turnover of 
(2S)~0‘phosphohomoserine, (2S,3S)-[3-^Hi]-0-phosphohomoserine 
and (2S)-[2-^H-\]-0-phosphohomoserine.
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Figure 2.23: The double reciprocal plot of threonine synthase activity with (2S)- 
O-phosphohomoserine, (2S,3S)-[3-^H^]-0-phosphohomoserine and 
(2S)-[2^Hi]-0-phosphohomoserine. Points are derived from the 
best-fit curves shown in Figure 2.22.
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Conclusions.
The above experiments reveal that both the and CP-H proton removal steps 
in the E. coli threonine synthase mechanism display primary deuterium isotope 
effects, and that cleavage of the C-3-(pro-S)-H bond is at least partially rate limiting.
The removal of the C“ -H proton from the external aldimine (53) to give the 
quinonoid intermediate (54) exhibits a small but significant kinetic isotope effect on 
V (Scheme 2.24). This indicates that the reaction is kinetically significant but is not 
slow compared to other steps in the reaction. As already stated, the value of ^(V/K) 
for removal of the C^-proton was unity. The fact that the value of is small but 
larger than the value of ^(V/K) for the 0 -2  deuteriated compound strongly suggests 
that the high forward commitments to both the C^-H and QP-H proton removal 
steps) occur because transaldimination in the reverse reaction direction and/ or 
substrate debinding is very slow.
The p,y-elimination of phosphoric acid from the quinonoid intermediate (54) to give 
the conjugated enamine (55) was confirmed to take place with the loss of the 
3-pro-S proton. This confirms that the E. coli enzyme has the same stereochemical 
path as the yeast enzyme at this point.^^^ The kinetic isotope effect on the value of 
of 1.75 suggests that this step in the mechanism of threonine synthase is at 
least partially rate-limiting. The value of ^{V/K) for the ( 2 S , 3 S ) - [ 3 -^ Hi ] - 0 -  
phosphohomoserine was unity, again pointing towards a high forward commitment 
to the reaction. This suggests that the steady-state concentration of the quinoid 
(54) is quite high.
In addition, this work confirms that S-adenosyl methionine behaves as an activator 
of E. C O //threonine synthase. This is, to our knowledge, the first documented report 
of a prokaryotic threonine synthase being activated in this way. A full kinetic
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analysis of the activation of TS from E. coli by SAM, determining the Hili coefficient 
for the activation would confirm that the bacterial enzyme behaves in the same way 
as that of plants.
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Scheme 2.24: The proposed mechanism of E. coli threonine synthase.
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2.5 Phosphohomoserine Analogues.
In order to further investigate the mechanism of threonine synthase especially with 
reference to C-4, it was neccessary to synthesise 4-methyl phosphohomoserine
(83). If either the (4S)- or (4A)-methyl phosphohomoserines were turned over as 
substrates, we would be able to infer the spatial availability around C-4 of the 
substrate and perhaps the geometry of the reactions occurring at 0 -4 . The 
protected oxopentanoate (84) was envisaged as a possible synthetic intermediate 
for the methyl analogues.
NH2 Me NHg Me
„ o . o ^ o - ü c “
(83) (84)
Baldwin et al. have reported the synthesis of of (2 S )-b e n zy l 2 -(f-  
butyloxycarbonylamino)-4-oxopentanoate (85) from (2S)-aspartic acid dibenzyl 
ester p-toluenesulfonate (86 ) in 5 s t e p s . W e  decided to repeat this work in 
order to obtain substantial amounts of the starting material.
(2 S)-Aspartic acid dibenzyl ester p-toluenesulfonate (86 ) was extracted into ethyl 
acetate from a solution of K2CO3 to provide the free amine (87). Cyclisation to the 
p-lactam involved the formation of (2S)-A/-(trimethylsilyl)dibenzyl aspartate by 
reaction with TMSCi and EtgN in diethyl ether. Treatment of this species in s/fu with 
f-butyl magnesium chloride led to the formation of the azetidinone (8 8 ) in good 
yield, showing the p-lactam C = 0  IR signal at 1780 cm "\ N-protection of the 
azetidinone with Boc anhydride and a catalytic amount of DMAP yielded the fully 
protected azetidinone (89), the CHg's of the Boc group clearly visible in the  ^H- 
NMR spectrum at 1.44 ppm. This protected azetidinone was reacted with
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trimethylsulfoxonium Iodide and sodium hydride in DMSO to give the sulfoxonium 
ylide (90) in almost quantitative yield.
The sulfoxonium ylide (90) thus obtained was a relatively stable species and was 
carried forward to the next step without further purification. Reduction of the ylide 
with hydrogen iodide gave the desired oxopentanoate (85) only in a moderate 
yield of 48% (§h 2.12 ppm C(0 )CÜ3). In an attempt to improve the yield of the 
desired oxopentanoate (85) an equivalent of potassium iodide was added to the 
reaction mixture. This, however, lead to the additional formation of the iodomethyl 
ketone (91) (8 h  3.78 ppm C(0 )CH2l). The synthesis of protected oxopentanoate
(84) by this route was of interest, but was not suitable for our needs (Scheme 2.25). 
The introduction of several extra steps was our main concern.
NH3
H-yv.^C02Bn
BnOgC
(86)
+
PTSA-
NH2 .. ,C 0 2 Bn
BnOgC 'h
(87)
ill AO' Boc 
(89)
Boc^pOgBn NH O
Iv ^ H-'
BnOgC
y  
 I
(90) " f o -
Reagents: i) K2CO3, EtOAc; II) TMSCI, EtsN, EtgO, 
then 'BuMgCI, HCI, NH4CI. DCM; III) BocgO, DOM, 
DMAP; Iv) MegS+OI", NaH, DMSO; v) HI, KI, HgO.
(88)
Boc^
NH O
(85)
+
Boc^
NH O
^  m
Scheme 2.25: Baldwin's synthesis of 2-amino-4-oxopentanoate (85).
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We decided that a more efficient route would be to treat a suitably activated 
derivative of the already synthesised a-isopropyl /V-trifluoracetyl aspartic acid (75) 
with diazomethane to form the diazoketone, and to reduce this to the methyl ketone 
via treatment with hydrogen iodide. Thus the use of TMS-diazomethane as a safe 
alternative to diazomethane and its performance as a methylating agent was 
investigated.
Using the simple and readily available hydrocinnamic acid chloride (92) as a 
model substrate, this was reacted with a solution of TMS-diazomethane in hexane 
for two hours at 0 °C, Scheme 2.26. Reduction of the diazoketone was carried out 
in situ by addition of excess hydrogen iodide. It was thought that this reduction of 
the ketone would also result in the loss of the trimethylsilyi group. Although some 
of the desired benzylacetone (93) had indeed been formed, there were also 
several rearrangement products, as well as the ch loro methyl ketone. It was evident 
that although the reagent TMS-diazomethane could be used as a safe substitute 
for distilled diazomethane, in our case it was far from ideal.
Me
(92) (93)
Reagents: i) TMS diazomethane in hexane; ii) HI, H2O
Scheme 2.26: The synthesis of benzyl acetone using TMS-diazomethane.
The above strategies were therefore discarded in favour of a more direct route 
using methodology already developed in the group.^*^  ^ It was envisaged that N-
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trifluoroacetyl a-isopropyl aspartic acid (75) would readily yield the protected acid 
chloride (94) on treatment with thionyl chloride. This would then be reacted with 
diazomethane to furnish the diazoketone (95), which could be reduced with 
hydrogen iodide to give oxopentanoate ( 9 6 ) . The formation of the methyl 
ketone could also be envisaged by forming the mixed anhydride derivative of the 
acid (97) as before, and treating this with diazomethane followed by treatment with 
iodide (Scheme 2.27).
XFg C '^ N H
H "■ J>v^^C02H 
'PrCOaC
(75)
XFgC'^NH O 
(94)
O
XF aC ^N H  O Q
'PrCOaC ^
(97)
XFgC'^NH O 
'PrCOaC
(96)
Me
O
XF a C ^ N H  O 
(95)
Scheme 2.27: Strategy for the synthesis of 4-methylphosphohomoserine
Reduction of the ketone to the diastereomeric alcohols (98) with borohydride 
wouid allow estérification to the protected methyi analogue of phosphohomoserine 
(99) using the methodology developed earlier, i.e. by treatment with N ,N  
diisopropyl bisbenzylphosphoramidite and tetrazole, followed by oxidation with 
m-CPBA. Deprotection of the phosphate triester by hydrogenolysis and treatment
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with base would then allow the isolation of 4-methyl phosphohomoserine (83).
O
JJF3C""^ NH oh
'PrCOaC
(98)
Me
1FsC-^ NH Me
(99)
OHOH
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EXPERIMENTAL
Elemental microanalyses were performed in the departmental microanalytical 
laboratory.
NMR Spectra were recorded on a Bruker AM-300 (300 MHz; f.t. iH -N M R, 74.76 
MHz; 13C-NMR and 121.5 MHz; 31P-NMR), a Varian Gemini 200 (200 MHz; 1H- 
NMR, and 50.3 MHz; 13C-NMR) and a JEX GX 400 (400 MHz; f.t. iH -NM R, 100.6 
MHz; 13C-NMR) spectrometers. 1H-NMR spectra were referenced on ^hOH (4.68 
ppm), CHCI3 (7.27 ppm) or DMSO (2.47 ppm). 13C spectra were referenced on 
CH3OH (49.9 ppm), CHCI3 (77.5 ppm) or DMSO (39.70 ppm) and 31 p spectra on 
external H3PO4. NMR spectra are described in parts per million downfield shift 
from TMS and are reported consecutively as position (ôh or ôc), relative integral, 
multiplicity (s-singlet, d-doublet, t-triplet, q-quartet, m-multiplet, dd-doublet of 
doublets, sp-septet and br-broad), coupling constant (Jx,y Hz if applicable) and 
assignment.
Infrared spectra were taken on a Perkin-Elmer 1420 recording spectrometer 
and a Perkin Elmer 1710 f.t. I.R. spectrometer. The samples were prepared as 
Nujol mulls or thin films between sodium chloride discs. The frequencies (t>) as 
absorption maxima are given in wave numbers (cm-i) relative to a polystyrene 
standard. Mass spectra were recorded on a Kratos MS50, a JEOL DX 303, a VG 
TRIO 1 and obtained on an SERC service basis at the University of Swansea using 
a VG ZAB E. Major fragments are given as percentages of the base peak intensity. 
GC/MS spectra were recorded on a Hewlett Packard 5890A 60. U.V./ VIS. optical 
intensities were measured on a Cam Spec M302 spectrophotometer.
Flash chromatography was performed according to the procedure of Still et 
using Sorbisil 060  (40-60 pm mesh) silica gel. Analytical thin layer 
chromatography was carried out on 0.25 mm precoated silica plates (Macherey- 
Nagel SIL g/ UV254) or on 0.1 mm precoated cellulose plates (OEL MN 300-10/ 
U V254), and compounds were visualised by UV fluorescence, iodine vapour, 
ethanolic phosphomolybdic acid, aqueous potassium permanganate, acidic
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palladium ch io ri de or ninhydrin.
Melting points were taken on an Electrothermal melting point apparatus and 
are uncorrected. Optical rotations were taken at 23 °C on an Optical Activity AA- 
100 polarimeter using 10 cm path length cells.
The solvents used were either distilled or of analar quality and light 
petroleum refers to that portion boiling between 40 ° and 60 °C. Solvents were 
dried according to literature p r o c e d u r e s .2 3 2  Ethanol and methanol were dried 
using magnesium turnings, isopropanoi, DMF, C H 2 C I2 , acetonitrile, 
diisopropyiamine, triethylamine and pyridine were distilled over CaH2. THF and 
diethylether were distilled under nitrogen from the sodium ketal of benzophenone 
directly before use. N-Methylmorphoiine was distilled from ninhydrin before use.
Anion exchange chromatography was performed on DEAE Sephacel unless 
otherwise stated. The chromatographic media was dissolved in the appropriate 
buffer, left for 24 h, packed (100 x 15 mm) and used as such during the whole 
study.
Gel exclusion chromatography was performed using Sephadex G-150. The gel 
was suspended in the appropriate buffer and allowed to settle several times to 
remove fine particles. The column was repacked (80 x 3 cm) before each use to 
achieve maximum flow rates.
SDS-PAGE was performed following the procedure of Laemmli on a discontinuous 
m e d i u m . A  Mini-Protean Ii Dual Slab Cell apparatus was used.
Centrifugations were carried out on a CENTRIKON C-124 centrifuge. Pooled 
fractions from protein purification steps were concentrated by ultrafiltration using an 
AMICON apparatus (43 or 76 mm diameter), through a YM30 membrane under N2.
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All protein purification steps were carried out at 0-4 °C, and all materials used were 
of AR quality. Protein concentrations were determined by the method of 
B ra d fo rd .A p p ro p r ia te ly  diluted samples of protein solution were mixed with 
Coomasie blue dye reagent (100 mg of Coomasie brilliant blue dissolved in 50 ml 
of 95 % ethanol to which 100 ml of 85 % of phosphoric acid has been added and 
the whole diluted to 11 with water, and after 5 min the absorbance was measured at 
595 nm. Standard curves were prepared using bovine serum albumin.
E. co//Tir 8 were the kind gift of Prof. C. Parsot of the institut Pasteur, Paris. The 
cells were stored in 10 mi aliquots of 10 % glycerol solution at -80 °C. The 
innoculae were destroyed after 10 usages, to prevent spontaneous reversion to 
wild type after repeated freeze-thaw cycles.
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Dimethyl dideuterlofumarate (69).
002 /^10
Me02C
To a stirred solution of dimethyl acetylenedicarboxylate (68 ) (5 g, 35 mmol) in dry 
THF (70 ml) containing deuterium oxide (0.7 g, 35 mmol) was added drop wise 
triphenylphosphine (9.3 g, 35 mmol) in THF (70 ml). The reaction temperature was 
not allowed to exceed 5 °C during the addition. The reaction mixture was then 
allowed to warm to room temperature, before being refluxed for 5 h. The resultant 
solution was dried (MgS0 4 ), filtered, and the filtrate washed with dry THF. The 
solvent was removed under reduced pressure. The red/ brown tar was dried under 
vacuum and then sublimed at 80-100 °C to yield yellowish white crystals. 
Recrystallisation from methanol yielded the product (69) as white crystals (2.11 g, 
41%) of m.p, 98-100 °C (lit.,176 98-101 X ) ;  (Found: C, 49.45; H, 5.15. CsHsZHeOji 
requires C, 49.30; H, 5.15 %); D^ax (Nujol)/cm'i 2260 (C-^H), 1730 (ester C =0) and 
1610 (C=C); ÔH (200 MHz; ^HgO, 5% NaO^H) 3.81 (6 H, s, 2 x CH3); 6c (50.3 MHz, 
2H2O; 5% NaO^H) 51.6 (OCH3), 137.0 (t, J 12, alkenic C) and 177.49 (^OgMe); 
m/z (El) 146 {M+, 2%) and 59 (75, C0 2 Me+).
Dideuteriofumaric acid (70).
Dimethyl dideuterlofumarate (69) (2 g, 13.7 mmol) was added to 12 % NaOH 
(13 ml) with stirring for 72 h at room temperature. The pH was adjusted to 2 with 
3 M HCI and the acid precipitated out. The product was recrystallised from 8% 
NaOH using 3 M HCI to regenerate the un-ionized acid (70) (1.19 g, 66 %) of m.p. 
297-300 X ,  (lit.,176 299-300 X ) ;  (Found: 0 , 39.50; H, 3.40. C4H22H2O 4 requires
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c, 40.70; H, 3.40 %); D^ax {Nujol)/cm-i 2400-3400 (acid OH), 2260 (C-^H) and 
1680 (acid C =0); Ôq (50.3 MHz; ^HgO, 5% NaO^H) 133.10 (t, J  25, C=C) and 
172.88 (COgH); m/z (El) 118 (M+, 38%) and 101 (41, [M  - OH]+).
(2S,3S)-[2-2H i , 3-2Hi]Aspartic acid (45a) {Hx=Ha=2H}.
HgN COgH
Hx”"}— r*H A  
HOgC Hb
Dideuteriofumaric acid (70) (2 g, 16.9 mmol) was suspended in water (20 ml) and 
the pH adjusted to 9 with concentrated ammonia solution. The solution was then 
concentra ted  under reduced pressure. The diammonium fumarate was 
redissolved in water (20 ml), and magnesium chloride hexahydrate (40 mg, 10 
mmol), and potassium chloride (7 mg, 4.5 mmol) were added. The pH was again 
adjusted to 9 with concentrated ammonia, 3-methylaspartase (30 units) was added 
and the reaction was incubated at 30 °C until no further decrease in the 
absorbance at 240 nm occurred (about 3 days).
The solution was heated at 100 °C for 2 min and filtered through a Celite pad. The 
filtrate was acidified to pH 1 with 12 M HCI and extracted with ether ( 2 x 1 0  ml). 
The aqueous layer was adjusted to pH 4 and the aspartic acid (9a) crystallised out 
on addition of ethanol. The product was recrystallised from hot water/ ethanol to 
give the product as white crystals (1.39 g, 60 %) of m.p. 300 ‘^ C (decomp.); 
[a]o +24.7 (cO .6 in 6 M HCI) {lit.,204 [ajp +25.2 (cO .6 In 6 M HCI)}; -Umax (Nujol)/cm- 
1 3425 (N-H), 2656 (C-H), 2260 (C-2H). 2081 (C-2H) and 1688 (C =0); 5h (200 
MHz; ZHgO, 5% NaQ2H) 2.51 (1H, s, CP-H); Sq (50.3 MHz; ZHgC), 5% NaQ2H) 46.5
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(t, J 2 0 , CP), 56.0 (t, J  19, C«), 183.21 (p-COgH) and 185.33 (a-COgH); m/z (El) 
135 (M +, 3%), 44 (100, CO2+).
(25.35)-[3-2Hi]Aspartic acid (45b) {Ha=2H).
(25.35)-[3-2Hi]Aspartic acid (45a) (2.66 g, 20 mmol) was dissolved in water (50 
ml) and the pH adjusted to 7.25 with concentrated ammonia solution, aspartate 
aminotransferase (AAT) (200 units) and pyridoxal 5'-phosphate (5 mg) were added 
and the reaction incubated at 37 °C. The progress of the reaction was then 
followed by NMR. On completion of the reaction (approx. 72 h), the enzyme was 
denatured by boiling the solution for 2 min, and the solution filtered and 
concentrated under reduced pressure. The solid residue was dissolved in water 
(10 ml) and crystallised using 6 M HCI to yield the product (45b) as fine white 
crystals (2.09 g, 78 %), m. p. >300 °C; (Found: C, 35.80; H, 5.25; N, 11.30. 
C4H62HNO4 requires C, 35.80; H, 5.25; N, 10.45 %); [ajo +24.1 (c 0.6 in 6 M HCI) 
{lit.,204 23.9 (c 0.6 In 6 M HCI)}; 5h (200 MHz; 2H2O, 5% NaO^H) 2.58 (1H, d, J  2.4, 
CP-H) and 3.50 (1H, d, J 2.4, C«-H); 5c (50.3 MHz; ZHgO, 5% NaO^H) 45.8 (t, J 17, 
CP), 56.8 (C«), 183.2 (P-CO2H) and 185.3 (a-COgH).
(2S,3/7)-[3-2Hi]Asparlic acid (45c) {Hb=2H}.
This was prepared from fumaric acid (2 g, 17.2 mmol), as described above using 
deuterium oxide as the solvent. (2S,3R)-[3-2Hi] Aspartic acid was obtained as fine 
white crystals (1.55 g, 67 %); m.p. 290 °C (decomp.); (Found: C, 35.90; H, 5.25; N, 
10.90; M+, 135.0498. C4H62HNO4 requires: C, 35.80; H, 5.25; N, 10.45 %; M + , 
135.0516); [ajp +23.9 (cO .6 in 6 M HCI); u^ax (Nujol)Zcm-l 2740 (C-H), 2180 (C- 
2H), 1691 (C =0) and 1600 (N-H); 6h (200 MHz; 2H2O, 5% NaO^H) 2.35 (2H, br m,
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CP-H) and 3.41 (1H, d, J 6 .6 , C«-H); Sc (50.3 MHz; ZHgO, 5% NaO^H) 45.0 (t, J 15, 
CP), 56.47 (C“), 182.79 (P-COgH) and 184.10 (a-COgH); m/z (FAB) 269 (2 x [M  + 
H]+, 10%), 135 (100, [M +  H]+).
(2S)-[2-2Hi]Aspartic acid (45d) {Hx=2H}.
This was prepared In an Identical manner to that described for compound (45b) 
using (2S)-aspartlc acid (3 g, 22.5 mmol) as the starting amino acid and carrying 
out the enzyme Incubation In deuterium oxide. Recrystalllsatlon from water/ 
6 M HCI gave (2S)-[2-2Hi]-aspartlc acid as white crystals (2.19 g, 72 %); m.p. > 
300 X  (decomp.); [a]o +21.02 (c 0.95 in 6 M HCI) [lit.,1^3 +21.05 (c 0.95 in 6 M 
HCI)]; 'Umax (Nu]ol)/cm-i 3000-2500 (OH stretching), 1688 & 1643 (carboxylate 
anion) and 1586 (NH deformations); 5h (200 MHz; ^HgO, 5% NaO^H) 2.6 (2H, dd, J
1.3, J  15.3, CP-H); 8c (50.3 MHz; 2H2O, 5% NaO^H) 46.1 (CP), 56.5 (t, J 17.4, C«),
183.1 (P-CO2H) and 185.3 (a-C0 2 H); m/z (FAB) 135 ([M + H]+, 70 %) and 134 (30, 
M+).
Carbobenzyloxy (2S) aspartic acid (71).
(2 S)-Aspartic acid (2.63 g, 20 mmol) was dissolved in water (50 ml), overlaid with
ether (10 ml). To this was added to MgO (2.42 g, 60 mmol) and the solution was
stirred vigorously at 0 X .  Benzyl chloroformate (6.82 g, 40 mmol) was added in
five portions over 30 min, and the reaction left to stir for four days. The solution was
acidified to pH 2 with 1 M HCI, and then extracted with ethyl acetate (3 x 25 ml).
The organic extracts were dried (MgS0 4 ) and concentrated under reduced
pressure to yield a white crystalline solid. Recrystallisation from ethyl acetate/
petroleum ether gave the product (71) as white crystals (3.26 g, 62%); m.p. 114-
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115 °C (lit.,181 116 °C); [a]0  +4.5 (c 7.1 in acetic acid) [Iit.,i8i +9.6 (in acetic acid)]; 
U m a x  (Nu]ol)/cm-l 3360 (amide NH), 1720 (C=0) and 1540 (N-H stretch); 5h (200 
MHz; ds-DMSO) 2.65 (2H, ABX, Jba16.5, Jxa5.5, JxB 7-7, CP-Ha), 4.37 (1H, dd, J 
7.7, J 16.5, C“ -H), 5.06 (2H, s, benzyl CHg), 7.35 (5H, m, aromatic) and 7.65 (1H, d, 
J 8.4); 5c (50.3 MHz; dg-DMSO) 36.26 (CP), 45.63 (C“ ), 65.76 (PhCHg), 128.40 & 
128.64 (aromatic), 137.16 (4^ " aromatic), 156.16 (urethane C =0 ) and 171.95 & 
172.99 (COgH).
C arbobenzy loxy  (2S ) aspartic anhydride (72).
Trifluoroacetic acid anhydride (0.84 g, 4 mmol) was added to a stirred suspension 
of carbobenzyloxy-(2S)-aspartic acid (71) (3.7 mmol, 0.97 g) in dry THF (30 ml) 
over 30 min. The reaction was then left stirring for an additional 30 min. The 
solvent was removed under reduced pressure to yield a white crystalline solid 
which was recrystallised from ether/ petroleum ether to give pure (72) as a white 
solid (0.89 g, 96 %), m.p. 69-70 °C; u^ax (Nujol)/ cm-f 3410 (amide NH), 1805 
(0 = 0 ), 1685 (C =0) and 1535 (N-C=0); Sy (200 MHz; C^HCIg) 3.25 (2 H, ABX, CP- 
Hg), 4.5 (1H, m, Ca-H), 5.15 (2 H. s, PhCHg), 5.6 (1H, m, NH) and 7.35 (5H, s, 
arom atic); 6c (50.3 MHz; C^HCIs) 34.8 (CP), 68 (C«), 128 (benzyl), 136 (4o 
aromatic), 156 (0 = 0 ) and 168 & 175 (COgH); m/z (El) 249 (M +, 10%) and 107 (54, 
C6H5CHgO+).
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a-lsopropyl carbobenzyloxy (25) aspartate (73).
COpH
COgPr
The anhydride (72) (1.99 g, 8 mmol) was dissolved in cold dry isopropanol (30 ml) 
at 0 °C. The reaction was allowed to warm to room temperature and then left for 
15 h to complete dissolution. Isopropanol was removed under reduced pressure 
to leave a clear colourless oil which crystallised on standing. Recrystallisation from 
diethyl ether/ petroleum ether gave the product (73) as white crystals (1.36 g, 
55%); m.p. 112 °C; D^ax (Nujol)/cm-f 3420 (N-H), 1730 (C =0) and 1170 (C-O); 5h 
(200 MHz; C^HCIg) 1.25 & 1.27 (6 H, 2 x /PrCHg), 3.00 (2H, m, CPHg), 4.15 (1H, m, 
C«), 5.15 (2H, m, PhCHg), 5.95 (1H, d, J6 .5 , NH), 7.35 (5H, s, aromatic) and 8.18 
(1H, s, COgH); ÔC (50.3 MHz; C2HCI3) 14.6 & 21.5 ('Pr£H3), 37.0 (CP), 51.0 (C«), 
61.16 (/PrCH), 67.7 (Ph^Hg), 128.7 (aromatic), 136.1 (4*^  aromatic), 156.2 (urethane 
C =0), 169.21 (COa'Pr) and 172.33 (COgH); m/z (El) 309 (M +, 1%) and 264 (10, [M  
- COgH]+).
a-lsopropyl N-trlfluoroacetyl (25)-aspartate (75).
%
F3C NH COgH
H x -y —
'PrOgC Ha
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Trifluoroacetic anhydride (80 g, 381 mmol) was added dropwise over 30 min to a 
stirred suspension of (2S)-aspartic acid (6 g, 45.1 mmol) in dry THF (150 ml) at 
0 °C under an atmosphere of nitrogen. The reaction was allowed to warm to room 
temperature over 2 h when the solution became homogeneous. The solvent was 
removed under reduced pressure and the resulting white solid was thoroughly 
dried. Cold dry isopropanol (50 ml) was added and the reaction was allowed to 
warm to room temperature. The reaction was stirred for a further 48 h and the 
solvent was removed under reduced pressure to yield a clear oil which solidified 
on standing. Recrystallisation from ether/ petroleum ether yielded the product (75) 
as white crystals (11.2 g, 92 %), m.p. 98 °C lit.J^^ 98 °G; (Found: 0 , 39.90; H, 4.65; 
N, 5.25. G9H 12NO5F3 requires G, 39.90; H, 4.45; N, 5.15 %); [a]o -40.7 {c 1.0 in 
methanol); u^ax (Nujol)/cm -1 3311 (N-H), 1740 1708 & 1707
(superimposed GOg ’^Pr and GOgH), 1280 (G-O) and 1185-1106 (GF3); Ôh (200 
MHz; G2HGI3) 1.27 (6 H, dd, J 4.4, J 17.5, 2 x /PrGH3), 3.23 (2H, ABX, Jax = Jbx
4.3, Jab 17.7, GP-Hg), 4.77 (1H, dd, J 3.9, J 7.6, G«-H), 5.11 (1H, sp, J4 .5 , /PrGH) 
and 7.39 (1H, d, J 7.6, NH); Ôq (50.3 MHz; G2HGI3) 21.8 & 22.0 (/PrGH3), 35.7 (GP),
49.4 (G«), 71.5 (/‘PrGH), 116.0 (q, J  287, F3G), 157.6 (q, J 37.9 , F3GCO), 169.0 
(GOg/Pr) and 175.86 (p-GOgH); m/z (El) 272 ([M + H]+, 1%), 96 (21 , F3GGO+) and 
43 (100, [(GH3)gGH0H]+).
a-lsopropyl N-trlfluoroacetyl (2S,3Ff)-[3-2Hi]aspartate (75a).
This was prepared in an identical manner to that described for compound (75) 
using (2S,3f?)-[3-2Hi]aspartic acid (45c) (1.0 g, 7.5 mmol) as starting amino acid in 
90 % yield (1.84 g), m.p. 97-98 °G; u^ax (Nujol)/cm-i 3311 (N-H), 1740 (F3GG=0 ), 
1708 & 1707 (superimposed GOg/Pr and GOgH), 1280 (G-O) and 1185-1106 (GF3); 
5h (200 MHz; G2HGI3) 1.28 (6H, t, J 6 .0 , 2 x /PrGH3), 3.16 (1H, d, J4 .3 , GP-H), 4.83 
(1H, dd, J  3.9, J  6.2, G«-H), 5.11 (1H, m, J  6.3, /PrGH), 7.56 (1H, d, J 7.7, NH) and
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10.21 (1H, br s. COgH): 5c (50.3 MHz; C^HCIg) 21.8 & 22.0 ('PrOHg), 35.7 (t, Jc2h
6 .6 , CP), 49.3 (C“), 71.4 ('PrCH), 123.1 (q, J  288, FgC), 158.0 (q, J  37.8, F3CÜO),
169.0 (COg'Pr) and 176.0 (P-COgH); m/z (El) 227 ([M - C0 2 H]+, 7%), 213 (21, [M -  
0 CH(CH3)g]+), 140 (45, [M - C0 2 CH(CH3)g]+) and 43 (100, [CH(CH3)2]+).
a-lsopropyl N-trlfluoroacetyl (2S,3S)-[3-2Hi]aspartate (75b).
This was prepared in an identical manner to that described for compound (75) 
using (2S,3S)-[3-2Hi]aspartic acid (45b) (1.50 g, 11.2 mmoi) as starting amino 
acid in 91 % yield (2.78 g), m.p. 96-98 °C; u^ax (Nujoi)/cm-i 3311 (N-H), 1740 
(F3CC=0 ), 1708 & 1707 (superimposed COg'Pr and COgH), 1280 (C-O) and 1185- 
1106 (CF3); 8 h  (200 MHz; C^HCis) 1.28 (6H, t, J6 .0 , 2 x 'PrCHs), 2.93 (1H, d, J4 .3 , 
CP-H), 4.82 (1H, dd, V 3 .9 , J7 .7 , C«-H), 5.12 (1H, m, J 6 .3 , 'PrCH), 7.60 (1H, d, J
7.7, NH) and 8.43 (1H, br s, COgH); Sc (50.3 MHz; C^HCis) 21.84 & 21.96 ('PrCHg), 
49.40 (t, J5 .6 , CP), 71.47 ('PrCH), 116.0 (q, J287, P3C), 157.61 (q, J37.9, F3CÇO),
169.04 (a-COg'Pr) and 175.86 (P-CO2H); m/z (El) 227 ([M - C0 2 H]+. 10%), 213 (25, 
[/W- 0CH(CH3)g]+), 185 (40, [M - COgH - CH(CH3)g]+), 167 (22 , [M -C O gC H (C H 3)2 
- OHg]+) and 43 (100, [CH(CH3)g]+).
a-lsopropyl N trifluoroacetyl (2S)-[2-^Hi]aspartate (75c).
This was prepared in an identical manner to that described for compound (75)
using (2S)-[2-2Hi]aspartic acid (45d) (1.15 g, 8.58 mmoi) as starting amino acid in
87 % yield (2.03 g), m.p. 95-87 °C; u^ax (Nujoi)/cm-l 3311 (N-H), 1740 (FgCC^O),
1708 & 1707 (superimposed COg'Pr and COgH), 1280 (C-O) and 1185-1106 (CF3);
5h  (200 M H z;C 2HCi3) 1.22 & 1.25 (6H, d, 'PrCHs), 3.04 (2H, q, J18.7 , CP-Hg), 5.07
( 1H, sp, J5 .9 , 'PrCH), 7.55 (1H, d, J7 .9 , NH) and 10.08 (1H, brs, CO2H); Sc (50.3
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MHz; C2HCI3) 21.65 & 21.79 ('PrCH3), 35.6 (t, J9 .2 , C«), 49.2 (CP), 71.5 {'PrCH), 
116 (q, J 2 8 7 , F3C), 157.6 (q, J38.1 , FsC^O), 169.0 (COa'Pr) and 175.9 (CO2H); 
m/z (El) 227 ([M -  C0 2 H]+, 5%), 213 (15, [M - OCH(CH3)2]+), 185 (48, [M  - CO2H - 
CH(CH3)2]+), 167 (22 , [M - C0 2 CH(CH3)2 - 0 H2]+), 140 (45, [M -  C02CH(CH3)2]+) 
and 43 (100, [CH(CH3)2]+).
a-lsopropyl A^-trifluoroaoetyl (2S) homoserine (76).
PrOpC
The a-isopropyl ester (75) (1 g, 3.9 mmol) was dissolved in dry THF (15 ml) and 
the solution cooled to -50 °C. A/-Methylmorpholine (0.39 g, 3.9 mmol) and isobutyl 
chloroformate (0.506 g, 3.9 mmol) were then added. A white precipitate formed 
immediately and after 5 min the solution was filtered into a solution of NaBH^ 
(0.10 g, 2.7 mmoi) in THF (10 ml) at -20 °C. The reaction was left to stir for 4 h, 
after which time water was added to destroy any excess boro hydride. The solution 
was evaporated under reduced pressure until water began to distill off, and then 
the aqueous phase was extracted with ether ( 3 x 1 5  ml). The ethereal layer was 
washed with brine, dried (IVIgSO^) and then evaporated to dryness under reduced 
pressure. The crude pale yellow oil was purified by flash chromatography [silica, 
eluting with ethyl acetate, petroleum ether and diethyl ether; (40:40:20) containing 
a few drops of glacial acetic acid] to yield the pure alcohol (76) as a clear oil 
(0.86 g, 92 %); (Found C, 42.45; H, 5.15; N, 5.45. Calc, for C9H14NO4F3 0: 42.05; 
H, 5.50; N, 5.45 %); m/z (Found: [M - C3H7 0 ]+ 198.0363. Calc, for C6H7NO3F3:
198.0378); [a]o -48.2 {c 1.75 in diethyl ether); D^ax (Nujol)/cm"f 3400-3000 (OH)
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and 1720 (ester C=0); 5h (200 MHz; C2HCI3) 1.28 (6 H, m, 2 x 'PrCH3), 1.9 (1H, m, 
CP-Hb), 2.17 (1H, m, CP-Ha), 4.67 (1H, dd, Jxa 4.32, Jxb 7.7, C«-H), 5.08 (1H, sp, J  
6.27, 'PrCH) and 7.64 (1H, d, J 2.1, NH); 5c (50.3 MHz; C2HCI3) 20.0 & 20.1 
('PrCHa), 34.5 (CP), 51.6 (C“), 59.2 (CY), 70.8 ('Pr£H), 126.0 (q, J 287, F3G), 158.0 
(q, J37.9  Hz, F3C £ 0 ) and 170.8 (ÜOg'Pr); m/z (Cl) ([M  + NH4]+, 60 %), (100, [M -  
C3H7 0 HJ+).
a-lsopropyl N-trlfluoroacetyl (2S,3/?)-[3-2Hi]homoserlne (76a).
This was prepared In an identical manner to that described for compound (76) 
using (2S,3H)-[3-2Hi]protected aspartate (75a) (0.57 g, 2.09 mmoi) as starting 
material in 86 % yield (.469 g); u^gx (Nujol)/cm-l 3400-3000 (OH) and 1720 (ester 
C =0); 5h  (200 MHz; C2HCi3) 1.18 (6H, m. 2 x 'PrCHs), 1 9 3  (1H, m, CP-Hb), 3.67 
(2 H, m, CY-H2), 4.57 (1H, t, J7.3, C«-H), 4.98 (1H, sp, J6 .3 , 'PrCH) and 8.06 (1H, d, 
J6.9 , NH); 8c (50.3 MHz; C2HCI3) 22.0 & 22.1 (2 x 'PrCHs), 33.6 (t, J4 .7 , CP), 51.6 
(C“), 59.2 (CV), 70.7 ('PrCH), 126.0 (q, V287, F3C). 158.0 (q, J 37.9, F3CÇO) and
170.6 (COs'Pr); m/z (Ei) 259 ([M  + H]+, 45 %), 241 (15, [M  - OH]+), 199 (70, [M  - 
0C H (C H s)2+], 171 (35, [M  - C02CH(CHs)2]+), 141 (60, [M  - C 02 C H (C H s )2 -  
HCOH]+), 57 (75, [0 CH(CHs)2]+) and 43 (100, [CH(CHs)2]+).
a-lsopropyl Af-trifluoroacetyl (2S,3S)-[3-8Hi]homoserlne (76b).
This was prepared in an identicai manner to that discussed for compound (76) 
using (2S,3fl)-[3-2Hi]protected aspartate (75a) (0.65 g, 2.34 mmoi) as starting 
materiai in 75 % yieid (0.462 g); u^ax (Nu]oi)/cm'i 3400-3000 (OH) and 1720 (ester 
C =0); Sh (200 MHz; C^HCis) 1.18 (6H, m, 2 x 'PrCHs), 2.17 (1H, m, CP-Ha), 3.67
(2H, m, CY-H2), 4.57 (1H, dd, J  4.2, J 6.4, C«-H), 5.09 (1H. sp, J 6.3, 'PrCH) and
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7.71 (1H, d, J 6 .9 , NH); ôc (50.3 MHz; C^HCIs) 22.1 & 22.2 (2 x /PrCHa), 33.6 (î, J 
7.2, CP), 51.6 (C«), 59.2 (Cï), 70.7 (/PrCH), 126.3 (q, J 287, F3C), 158.0 (q, J37.8 , 
F3C ^ 0 ) and 171.2 (COg/Pr); m/z (El) 259 {[M+  H]+, 40 %), 241 (18, [M -O H ]+), 199 
(60, IM  - O C H (CH3 )g]+), 171 (45, [M  - COgC H (C H 3 )g]+), 141 (50, [M  - 
COgCH(CH3)g- HCOH]+), 57 (80, [OCH(CH3)g]+) and 43 (100, [CH(CH3)g]+).
a-lsopropyl A^-trifluoroacetyl (2S)-[2-2Hi]honrioserme (76c).
This was prepared in an identical manner to that described for compound (76) 
using (2 S,3 R)-[3-2H1 jprotected aspartate (75a) (0.83 g, 3.05 mmol) as starting 
material in 75 % yield (0.59 g); o^ax (Nujol)/cm-i 3400-3000 (OH) and 1720 (ester 
C =0); ÔH (200 MHz; C^HCIs) 1.17 (6 H, m, 2 x /PrCH3), 1.93 (2H, m, CP-Hg), 3.67 
(2H, m, CT-Hg), 5.11 (1H, sp, J 6 .3 , /PrCH) and 7.75 (1H, d. J 6 .9 , NH); ôc (50.3 
MHz; C2HCI3) 22.0 & 22.1 (2 x /PrCH3), 33.7 (CP), 51.7 (t, J4 .7 , C«), 59.2 (CY), 70.7 
(/PrCH), 125.9 (q, J287 , F3 C), 158.0 (q, J 37.8, F3C ^ 0 ) and 170.7 (COg/Pr); m/z 
(El) 259 (IM +  H]+, 35 %), 241 (25, [M - 0 H ] + ) ,  199 (65, [ M  - 0CH(CH3)g+], 171 (45, 
[M  - C 0 g C H (C H 3 )g ]+ ), 141 (75, [M  - C 0 g C H ( C H 3 ) g -  HCO H]+), 57 (60, 
[OCH(CH3 )g]+) and 43 (100, [CH(CH3)2]+).
(2S)-Homoserine (49).
a-lsopropyl A/-trifluoracetyl (2S) homoserine (76) (1g, 3.89 mmol) was dissolved in
ethanol (20 ml). On addition of 1 M KOH (20 ml), the solution immediately warmed
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and became a deep, clear yellow colour. After 2 h the solution was neutralized 
with 1 M HCI and the solvent removed under reduced pressure. The resultant 
yellow material was applied to a column of Dowex SOW (H+ form). After washing 
with water (100 ml), the column was eluted with 0.1 M KOH. The ninhydrin positive 
fractions were pooled and concentrated under reduced pressure. The residue was 
recrystallised from water/ ethanol yielding (49) as a white crystalline solid (0.43 g, 
95%), m.p. 202-203 °C (decomp.), [lit.,^^^ 203 °C (decomp.)]; [a]o +21.2 (cO.5 in 1 
M HCI), (lit.,5 +20.4 (c 0.5 in 1 M HCI)}; Umax (Nujoi)/cm-1 3420 (NH), 3400-2400 
(acid OH), 1640 (acid C =0) and 1230 (C-O); 5h (200 MHz; ^HgO) 1.62 (2H, m, CP- 
Hg), 3.14 (1H, dd, C“-H) and 3.49 (2H, t, CY-Hg); 8c (50.3 MHz; 2HgO) 34.57 (CP), 
56.12 (C«), 61.40 (CY) and 177.18 (COgH).
N,A^-Diisopropyidichlorophosphoramidite (80).
4
To a vigorously stirred solution of PCI3 (21.3 ml, 0.155 mol) in anhydrous diethyl 
ether (75 ml), at -20 °C, under an atmosphere of nitrogen, was added dropwise dry 
diisopropylamine (31.8 ml, 0.315 mol) in anhydrous diethyl ether (75 ml). After 
stirring for 2 h at -20 °C, the reaction was allowed to warm to room temperature and 
stirred for a further 1 h. The precipitated salts were removed by filtration, and the 
solvent removed under reduced pressure The residue was fractionally distilled to 
give the product as a colourless liquid (18.8 g, 60%), b.p. 80-81 °C/ 8 mm Hg; 
(Found C: 34.90; H, 7.00; N. 6.65. CeH uN PC Ig requires C, 35.65; H, 7.00; N, 
6.95%); m/z (Found: [M + H]+, 201.0240. C^Hi^NFCIg requires 201.0241); Ôh (200
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MHz; C2HCI3) 1.25 (12 H. d, J^eH 6.3, 4 x 'PrCH3) and 3.9 (2H, d sp, JpH 12.5, J 
Me H 6.3, 2 X 'PrCH); Sq (50.3 MHz; C^HCW 23.9 (d, J pc 8.5, 'Pr£H3) and 47.7 (d, J 
PC 14, 'PrC.H); Sp (121.5 MHz; C2HCI3), 169; m/z (El) 203 & 201 (M + , chlorine 
isotopes, 7 & 14 %), 186 (64, [M - CH3]+), 166 (47. [M - Ci]+), 144 (49, Ci2P'Pr+) 
and 88 (93, PN'Pr+).
Af,Af-Diisopropylbis(P-cyanoethyl)phosphorainidate (78).
4
To diisopropyldichlorophosphoramidite (80) (5.05 g, 25 mmol), in anhydrous 
dichloromethane (20 ml), at -10 °C under a nitrogen atmosphere was added a 
solution of 3-hydroxypropionitrile (4.6 g, 65 mmol) and anhydrous triethylamine 
(6.6 g, 65 mmol) in anhydrous dichloromethane (20 ml). The reaction was stirred at 
-10 °C for 30 min, and then warmed to room temperature and stirred for a further 4 
h. The reaction was washed with 100 mM phosphate buffer, brine, dried (IVIgSO^) 
and the solvent removed under reduced pressure. The product was purified on a 
basified silica column using dichloromethane, to yield a clear oil (3.9 g, 61 %); m/z 
(Found, M+, 271.1462. C12H22N3O 2P requires 271.1460); D^ax (neat)/cm’ l 3000 
s, 2260 w (CN), 1030 vs, 730 s; 6h (200 MHz; C ^H C y 1.20 (12H, d, Jms-h 7, 4 x  
/PrCHs), 2.63 (4H, t, 6.4, 2 x CHgCN) and 3.68 (6 H, m, 2 x /'PrCH & 2 x POCHg); 
ÔC (50 MHz; C2HCI3) 20.5 (d, Jp,poc 6.7, CHgCN), 24.6 (d, Jpc 8.1, /Pr-CH3), 43.5 
(d, Jpc 13.4, /PrC), 58.6 (d, Jpc 18.8, POC) and 118.0 (CN); ôp (36.2 MHz; C ^H C y  
139; m/z (El) 271 (M+, 7%), 256 (35, [M -  CH3M , 201(25, [M -0 (C H g )g C N M , 171 
(95, [P(0(CHg)gCN)g]+) and 70 (15, [0(CHg)gCN]+).
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a-lsopropyl Af-trîfluoroacetyl (2S)-phosphohomoserîne biscyanoethyl
ester (77).
0 - P :
PrOpC
a-lsopropyl N-trifluoracetyl (2 S)-homoserine (76) (100 mg, 0.4 mmol) and 
1 H  - tetrazole (63 mg, 0.9 mmol) were added to THF (3 ml) under argon. 
Bis-(2-cyanoethyl) diisopropyl phosphoramidite (136 mg, 0.5 mmol) was then 
added to the solution and the reaction was followed by tic (50:50 ethyl acetate/ 
petrol; developing with iodine). After 1 h the solution was cooled in an ice bath and 
/77-CPBA (114 mg, 0.66 mmol) in dichloromethane (2 ml) was added dropwise. The 
reaction was stirred for 45 min, and then diluted with ether (5 ml), and washed with 
10% NagSOg, 1 M HCI, saturated NaHCOg and 100 mM phosphate buffer pH7 in 
succession. The organic fraction was dried with (NagSO#), filtered and the solvent 
removed under reduced pressure to leave the product (77) as a clear gum 
(154 mg, 87 %); Sh (200 MHz; C2HCI3) 1.22 (6 H, m, 2 x 'PrCH3), 2.23 (2H, m, 
CP-Hg), 2.78 (4H, t, J  7.5, HgCCN), 4.26 (6 H, m, CY-Hg & 2 x POCHg), 4.66 (1H, dd, 
JxA 4.3, Jxb 7.7, C“-H), 5.05 (1H, sp, J 6.7, 'PrCH) and 7.5 (1H, d, J  2.1, NH); Sq 
(50.3 MHz; C^HCIg) 20 (d , J7.3 , POC), 22 ('PrCHg), 32 (d, Jpc 5.3, CP), 50 (C«), 63 
(t, J  5.1, 2 X -GCN), 65 (d , Jpc 5.8, CY), 71 ('PrCH), 116 (q, Jpc 290, F3C), 117 
(CN), 158 (q, JcF 38, FgC£10) and 170 (ÛOg'Pr).
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N ,N  D iisopropyld ibenzylphosphoram idate  (81).
This was prepared in an identical manner to that described for compound (78) 
using benzyl alcohol instead of cyanoethanol in 65 % yield. The crude 
phosphoramidite was purified by silica chromatography using 30% ethyl acetate in 
petroleum ether as the eluant to give the pure compound (81) as a clear oil (5.2 g, 
72 %); m /z (Found: [M  + H]+ 346.1936. C20H29NO2P requires 346.1936); D^ax 
(neat)/cm-i 3000 (CH), 1600 (aromatic), 1010 (P-0), 750 and 700 (CH aromatic out 
of plane); Ôh (200 MHz; C2HCI3) 1.3 (12H, d, J 6 .8 , 4 x ^PrCHs), 3.8 (2H, m, 2 x 
PrCH), 4.8 (4H, t, J  6 .8 , 2 x PhCH2) and 7.4 (10H, m, aromatic); ôq (50.3 MHz; 
C2HCI3) 25.1 (d, J  7.3, 4 X P rC H 3), 43.6 (d, J  12.2, 2 x PrCH), 65.9 (d, Jcp 181 
Hz, 2 X PhCH2), 127.51,127.7 & 128.8 (aromatic CH) and 140.1 (aromatic 4° C); ôp 
(121.5 MHz; C^HCW 148.1; m/z (Cl) 346 ([M + H]+, 100 %), 238 (5, [A4 - BnO]+) and 
91 (10, Bn+).
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a-isopropyl N-trifluoroacetyl (2S)-phosphohomoserme dibenzyl ester
(82).
PrOpC
To a mixture of a-lsopropyl AZ-thfluoracetyl (2S)-homoserlne (76) (100 mg, 
0.4 mmol) and 1-H  tetrazole (84 mg, 1.2 mmol) In anhydrous dichloromethane 
(10 ml) was added N ,N  dllsopropyldlbenzylphosphoramldlte (81) (127 mg, 
0.4 mmol). The reaction was stirred at room temperature for 2 h before being 
cooled to -40 °C, and m-CPBA (138 mg, 0.8 mmol) In dichloromethane (5 ml) was 
added dropwise. The resulting solution was stirred at 0 °C for 45 min before being 
diluted with dichloromethane (40 ml), washed with NagSOg (10 %, 2 x 20 ml), 
NaHCOg ( 2 x 1 5  ml), water (15 ml) and brine (15 ml). The crude product obtained 
was purified by flash silica chromatography using 25 % ethyl acetate In petroleum 
ether as the eluant to yield the pure phosphate triester (82) as a clear oil (190 mg, 
92 %); m/z (Found: [M + H]+, 518.1556. C23H27NO7PF3 requires 518.1555); [ajp 
+3.04 (c 2.7 In diethyl ether); 6h (200 MHz; C2HCI3) 1.22 (6H, m, 2 x /PrCHg), 2.18 
(2H. m, CP-Ha), 4.0 (2H. q*, J  6.3, CY-Hg), 4.33 (1H, dd, Jax 6 .6 , Jqx 13.5, C“ -H),
5.0 (5 H, m, 'PrCH and 2 x benzyl CHg), 7.34 and 7.35 (10H, aromatic CH) and 7.63 
(1H, d, Jnh,x7.6, NH); 8c (50.3 MHz; C^HCIg) 22.0 & 22.1 (fPrCHa), 31.8 (d, Jpc 27, 
CP), 50.7 (C“ ), 64.1 (d, Jpc 22, CY), 70.0 & 70.1 (benzyl CHg), 70.8 ('PrCH), 116 (q, 
JcF 290, F3C), 128.5, 129.1 & 129.2 (aromatic CH), 143.2 (benzyl 4° C), 158.1 (q, 
JcF 38, F3C £0) and 169.9 (COg'Pr); Sp (121.5 MHz; C^HCIg) -0.55 . 
q* = pseudo quartet arising from the phosphorus splitting of a triplet.
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a-lsopropyl /V-trifluoroacetyl (2 S ,3 f? )-[3 -2H i]p h o sp h o h o m o serin e
dIbenzyl ester (82a).
This was prepared in an identical manner to that discussed for compound (82) 
using (2S,3A)-[3-2Hi]a-lsopropyl A/-trlfluoracetyl homoserine (76a) (0.50 g, 1.94 
mmol) as alcohol In 85 % yield (0.855 g); Ôh (200 MHz; C^HCIg) 1.24 (6 H, m, 2 x 
/PrCHs), 2.16 (1H, m, CP-H), 4.15 (2 H, m, CY-Hg), 4.55 (1H ,t, J7 .2 , Qa-H), 5.0 (5H, 
m, 'PrCH and 2 x benzyl CHg), 7.33 & 7.36 (10H, aromatlcs) and 7.94 (1H, d, J 7.7, 
NH); ÔC (50.3 MHz; C^HCIg) 22.1 & 22.0 ('PrCHg), 31.5 (t, JczH 4.6, CP), 50.5 (C«), 
64.2 (d, Jpc 21, CY), 70.0 & 70.1 (benzyl CHg), 70.7 ('PrCH), 115.0 (q, J rc  288, 
F3C), 128.6, 129.1 & 129.2 (aromatic CH), 142.9 (benzyl 4° C), 159.0 (q, J fc  39, 
F3CC.O) and 169.8 (COg'Pr); ôp (121.5 MHz; C^HCIg) -0.57.
a-lsopropyl /V-trlfluoroacetyl (2S ,3S )-[3 -2H i]phosphohom oserine  
dibenzyl ester (82b).
This was prepared In an Identical manner to that described for compound (82) 
using a-lsopropyl N-trlfluoracetyl (2S,3S)-[3-2Hi]hom oserlne (76b) (0.425 g, 
1.65 mmol) as alcohol In 87 % yield (0.742 g); ôh (200 MHz; C2HCI3) 1.24 (6H, m, 
2 X 'PrCH3), 2.16 (1H, m, CP-H), 4.55 (1H, t, J7 .2 , C«-H), 5.0 (5H, m, 'PrCH and 2 x  
PhCHg), 7.33 & 7.36 (10H, aromatlcs) and 7.94 (1H, d, J 7 .7 , NH); Ôq (50.3 MHz; 
C2HCI3) 22.1 & 22.0 C'PrCH3), 31.5 (t, J 4.6, CP), 50.5 (C«), 64.2 (d, Jpc 21, CY),
70.0 & 70.1 (PhCHg), 70.7 ('PrCH), 115.0 (q, J fc  289, F3C), 128.6, 129.1 & 129.2
(aromatic CH), 143.0 (aromatic 4° C), 158.8 (q, Jpc 39, F3CC.O) and 170.1 
(COg'Pr); ôp (121.5 MHz; C2HCI3) -0.53 .
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a-lsopropyl N-trifluoroacetyl (2S)-[2-2Hi]phosphohomoser[ne dIbenzyl
ester (82c).
This was prepared in an identical manner to that described for compound (82) 
using a-lsopropyl A/-trlfluoracetyl (2S)-[2-2H i]hom oserlne (76c) (0.675 g,
2.6 mmol) as alcohol In 76 % yield (1.030 g); (200 MHz; C^HCIg) 1.23 (6 H, m,
2 x /PrCHg), 2.16 (1H, m, CP-H), 4.04 (2 H, dq, J 7.1, J 9.3, CY-Hg), 5.03 (5H, m, 
'PrCH and 2 x PhCHg), 7.32, 7.34 & 7.36 (10H, aromatic) and 7.65 (1H, d, J 6.9, 
NH); 6c (50.3 MHz; C^HCIa) 22.1 & 22.0 ('PrCHg), 31.5 (CP), 50.5 (t, J4 .8 , C«), 64.2 
(d, Jpc 21 , CY), 70.0 & 70.1 (PhCHg), 70.7 ('PrCH), 115.0 (q, J fc  288, F3C), 128.6,
129.1 & 129.2 (aromatic), 142.9 (benzyl 4° C), 159.0 (q, J fc  39, F3C1QO) and 169.8 
(COg'Pr); 6p (121.5 MHz; C ^H C y -0.54.
(2 S )-0 -P h o s p h o h o m o s e rin e  (43).
Hx’«NHo 0  _J  '■
HOgC'
To a-lsopropyl A/-trlf!uoracetyl phosphohomoserlne dIbenzyl ester (82) (500 mg, 
10 mmol) dissolved In methanol (15 ml) was added 10 % palladium on charcoal 
(50 mg). The mixture was purged with dIhydrogen gas, and dIhydrogen was 
bubbled through the stirring suspension 6 h. The mixture was filtered through a 
Celite pad, evaporated to dryness and taken up In ethanol (10 ml). On addition of 
1 M KOH (10 ml), the solution Immediately turned yellow, and was left stirring for 
3 h. The solution was concentrated under reduced pressure and the resulting 
yellowish solid was subjected to ion-exchange chromatography (Dowex 50-W 200-
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400 mesh, 8 % cross-linked) eluting with water. The fractions were analysed by tic 
[isopropanol:water:concentrated ammonia solution; (26:6:5)] developing with 
ninhydrin. The fractions containing the product (43) were lypholized to yield a 
white solid (155 mg, 80%), m.p. 170 °C; m /z  (Found: [M  + H]+, 200.0328. 
C4H11NO6P requires 200.03240); [a]o +4.19 (c2 .4  in HgO) {iit.,i''4 [a]o + 4.21 (c
2.4 in water)}; 8h (200 MHz; ^HgO) 2.23 (2 H, m, CP-Hg), 4.01 (2H, t, Jab.X 11-4, d, 
J a b .p  5.49, CYHg) and 4.12 (1H, dd, J a x  12.4, Jgx 4.9, C“-H); 8c (50.3 MHz; 2HgO) 
38.7 (d, Jpc 7.4, CP), 56.3 (C“), 64.3 (d, Jpc 4.9, CY) and 186.2 (COgH); 8p (121.5 
MHz; 2HgO) 0.245; m/z (FAB) 200 { [M+ H]+, 20 %).
(2S,3H)-[3-2Hi]0-Phosphohomoserine (43a).
This was prepared in an identicai manner to that described for compound (43) 
using a-isopropyi W-trifiuoracetyi (2S,3R)-[3-2Hi]phosphohomoserine dibenzyi 
ester (82a) (0.785 g, 1.5 mmoi) as starting materiai in 83 % yieid (0.250 g), m.p. 
168-169 “C; 8h (200 MHz; 2HgO) 2.03 (2H, m, CP-H) and 4.0 (3H, m, C“ -H and 
CY-Hg); 8c (50.3 MHz; 2HgO) 34.3 (t, Jc2h 4.7, CP), 55.3 (C«), 65.0 (d, Jpc 5.0, CY) 
and 181.3 (COgH); 8p (121.5 MHz; 2HgO) 0.251.
(2S,3S)-[3-2Hi]0-Phosphohomoserine (43b).
This was prepared in an identicai manner to that described for compound (43) 
using a-isopropyi A/ trifiuoracetyi (2S,3S)-[3-2Hi]phosphohomoserine dibenzyi 
ester (82b) (0.685g, 0.13 mmoi) as starting materiai in 81 % yieid (0.213 g), m.p.
167-169 °C; 8h (200 MHz; 2HgO) 2.34 (1H, m, CP-H), 4.06 (2H, m, CY-Hg) and 4.16 
(1H, t, J4 .5 , C“-H); 8c (50.3 MHz; 2HgO) 34.2 (t, Jc2h 4.6, CP), 54.9 (C“), 64.8 (d, 
Jpc 5.0, CY) and 182.4 (COgH); 8p (121.5 MHz; 2HgO) 0.240.
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(2S)-[2-2Hi]0-Phosphohom oserine (43c).
This was prepared in an identical manner to that described for compound (43) 
using a-isopropyl A/-trifluoracetyl (2S)-[2-2Hi]phosphohomoserine dibenzyi ester 
(82c) (0.855 g, 1.6 mmol) as starting material in 78 % yield (0.257 g), m.p.
168-169 °C; Ôh (200 MHz; ^HgO) 2.34 (2 H, m, CP-H) and 4.06 (2 H, m, CY-Hg); ôq 
(50.3 MHz; ^HgO) 34.2 (CP), 54.9 (t, J  4.8, C«), 64.8 (d, Jpc 5.0, CY) and 182.4 
(COgH); ôp (121.5 MHz; ^HgO) 0.239.
(2 5 )-D ib e n zy l aspartate  (87).
H-Js^COgBn
BnOgC
(2S)-Aspartic acid dibenzyi ester p-toluenesulfonate (86 ) (40.98 g, 84.5 mmol) and 
potassium carbonate (34.97 g, 253 mmol) were dissolved in distilled water (500 ml) 
and the solution extracted with ethyl acetate (3 x 250 ml). The organic layer was 
washed with saturated brine (500 ml), dried (MgSO^) and the solvent removed 
under reduced pressure to yield free amine (87) as a clear oil (26.24 g, 90%); m/z 
(Found: [M~ COgBn]+, 178.0859. C10H12NO2 requires 178.0860); Dmax (neat)/ cm-f 
1740 (s, C =0), 1500 (w), 1455 (w) and 1170 (m); Ôh (400 MHz; C^HCIg) 2.05 (2 H, 
br s, NHg), 2.73-2.96 (2H, m, 3-H), 3.82-3.92 (1H, m, 2-H), 5.13 & 5.16 (2H, s, 
PhCHg) and 7.33-7.37 (10H, m, aromatic); Ôq (125 MHz; C^HCIg) 38.7 (3-C), 51.2 
(2 -C), 66.6  & 67.1 (PhCH2), 127.0-128.7 (Ph), 135.6 & 135.7 (Ph ipso C), and
171.2 & 174.2 (C=0).
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(4S) Benzyl azetldln-2-one-4-carboxylate (88).
BnOgC
To a solution of (2 S)-dibenzyi aspartate (87) (12.6 g, 40 mmol) in diethyl ether (55 
ml) at 0 °C was added trimethylohlorosilane (5.8 ml, 46 mmol). After 15 min 
triethylamine (6.4 ml, 46 mmol) was added and a white precipitate immeadiateiy 
formed. After 1 h the resulting suspension was filtered under an inert atmosphere, 
and the filtrate diluted with diethyl ether (100 ml). Dropwise addition of 
f-butylmagnesium chloride (23.0 ml of a 2 M solution in diethyl ether, 46 mmol), 
over 45 min yielded a suspension in a pale yellow oil. This suspension was 
allowed to warm to room temperature and stirred overnight. The mixture was again 
cooled to 0 °C and 2 M HCI saturated with NH4CI (80 ml) was carefully added, the 
organic layer was separated. The aqueous phase washed with DCM (2 x 60 ml) 
and the combined organic portions were then washed with saturated NaHCOg 
(100 ml), brine (100 ml) and dried (IVIgSO^). Removal of the solvent under reduced 
pressure yielded a white dispersion in a pale yellow oil, which crystallised from 
DCM to give (88 ) as white flakes (5.60 g, 69 %), m.p. 138-139 °C (lit,^^^ 138-139 
°C); Rp 0.5 (EtOAc:DCM 4:1); m/z (Found: [M - CHg(OC)]+, 163.0625. C9H9NO2 
requires 163.063323); 'o^ax (Nujol)/cm-i 3450 (m), 1780 (s, p-lactam C =0), 1748 
(m, ester C =0), 1350 (w), 1265 (m) and 1045 (w); Ôh (400 MHz; C^HCW 3.09 (1H, 
ddd, J 2, 3, 15, 3-H), 3.35 (1H, ddd, J 1, 6 , 15, 3-H), 4.22 (1H, dd, J 3, 6 , 4-H), 5.22 
(2 H, s, PhCidg), 6.11 (1H, brs, NH) and 7.34-7.42 (5H, m, aromatic); Ôq (125 MHz; 
C2HCI3) 43.3 (3-C), 47.2 (4-C), 67.4 (Ph-^Hg-O), 128.6-128.8 (Ph), 125.1 (Ph ipso 
C), and 166.8 & 171.2 (2 x C=0); m/z [DCKNH3)] 223 ([M + NH^j^, 100 %), 2.6 (43, 
[M +  H]+), 178 (47), 108 (36) and 91 (CyHy+,54).
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(4S)-Benzyl N-(f-butoxycarbonyl) azetldin-2-one-4-carboxytate (89).
BnOgC 
, L" H
O BOG
(4S)-Benzyl azetidin-2-one-4-carboxylate (8 8 ) (2.00 g, 9.7 mmol), di-f-butyl 
dicarbonate (4.25 g, 19.5 mmol), and DMAP (12.2 mg, 0.1 mmol) were stirred in 
aceto nit rile (20 ml) for 24 h. The solvent was removed under reduced pressure 
and the residue was redissolved diethyl ether (50 ml). The resulting solution was 
then washed with 1 M potassium hydrogensulfate (2 x 60 ml), saturated NaHCOg 
(40 ml), brine (60 ml), and dried (IVIgSO^), and the solvent removed under reduced 
pressure to yield a pale brown oil which was purified by flash chromatography 
[silica, eluting with diethyl ether/ hexane; (1:1)] to afford (89) as a colourless oil 
(2.51 g, 85 %), Rp 0.6 (EtgO); m/z (Found: [M -C^Hg]^, 249.06229. C 12H 11NO5 
requires 249.055169); Dmax (neat)/cm-i 1822 (s, p-lactam C =0), 1745 (m, ester 
C =0), 1375 (m), 1340 (s), 1155 (m) and 1050 (m); Ôh (400 MHz; C^HClg) 1.44 [9H, 
s, C0 2 C(CH3)3], 2.96 (1H, dd, J 3  and 12, 3-H), 3.24 (1H, dd, J 6 and 16, 3-H), 4.41 
(1H, dd, J 3  and J 6 , 4-H), 5.20 & 5.25 (2H, ABq, Jab 12 , PhCjH.2) and 7.29-7.31 
(5H, m, aromatlcs); Ôq (125 MHz; G2HCI3) 27.7 [C0 2 C (£H 3)3], 41.2 (3-0), 49.5 (4-
0 ). 67.5 (PhO-HgO), 84.0 [0 0 2 ^ ( 0 H3)g], 128.3-128.8 (Ph-0), 134.9 (Ph ipso 0 ),
147.0 (N^lOgFBu), and 162.5 & 169.4 (0 = 0 ); m/z [DC^NHg)] 323 ([M + NH43+, 
43%), 306 (7, IM  + H]+), 223 (100, [(M-GO2C4H8) + H]+), 108 (21), and 91 (27, 
C 7 H 7 + ) .
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(2S)-Benzyl 2 -[(f-bu ty loxycarbonyl)am îno]-5 -(d im ethylsu ifoxon ium
methylide)-4-oxobutanoate (90).
NH O
Bn02C
To sodium hydride (0.274 g of a 50% dispersion) and trimethyIsuIfoxonium iodide 
(1.48 g, 6.76 mmol) was added anhydrous DMSO (20 ml). After the initial 
effervescence the resulting mixture was stirred for 1 h. A solution of azetidinone 
(89) (1.52 g, 5.2 mmol) in DMSO (10 ml) was then added. The resulting deep 
yellow solution was stirred for exactly 15 min before being diluted with ethyl acetate 
(100 ml) and washed with water (100 ml). The resulting aqueous portion was re­
extracted with ethyl acetate (3 x 50 ml) and the combined organic portions were 
further washed with water (2 x 200 ml), and brine (200 ml). After drying (MgSO^), 
the solvent was removed under reduced pressure to yield (90) as an orange oil 
(1.96 g, 95 %) that required no further purification, Rp 0.2 (EtOAc); D^ax (neat/ cm-i) 
3362 (m), 3065 (m), 3010 (m), 3010 (m), 2977 (m), 1717 (s, C =0), 1570 (s), 1491 
(s), 1453 (s), 1247 (s), and 1045 (s); Ôh (400 MHz; C^HCIg) 1.51 (9H, s, 
C0 2 C(CH3)3), 2.75-2.90 (2H, ABX, Jab 22 Hz, Jax 4, Jbx 6 , 3-H), 3.21 & 3.32 (2 x 
3H, 2 X s, S(CH3)2), 4.31 (1H, s, 5-H), 4.50 (1H, m, 2-H), 5.18 (2H, ABq, J 15, 
C0 2 CÜ2Ph), 5.95 (1H, d, J 1 1 , NH), and 7.28-7.38 (5H, m, aromatic); Ôq (125 MHz; 
C^HCIg) 28.35 (C02C(£1H3)3), 41.20 (3-C), 41.87 & 42.04 (S (^H 3)2), 51.10 (2-C), 
66.81 (C02^1H2Ph), 70.36 (5-C), 79.57 (002^1(0H3)3) 128.16, 128.21 & 128.48 
(Ph-C), 135.86 (Ph ipso C), 155.73 (H H Q p2 Î-Bu), 172.06 (C.H=CO), and 186.19 
(0 = 0 ); m /z (El) 398 (M+, 15 %), 324 (10), 177 (30), 128 (25), 119 (100), 91 (90, 
C7H7+), and 57 (90, C4H9+).
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(2S)-Benzyl 2-(f-butyloxycarbonyiamino)-4-oxopentanoate (85)
BOG,
NH O
To a solution of (2S)-benzyl 2 -(/-butyloxycarbonylamlno)-5 -(dimethyl sulfoxonlum 
methylide)-4-oxobutanoate (90) (122 mg, 0.3 mmol) In DMF (5 ml). In a brown 
glass vessel, was added hydrolodio acid (46 ml of a 57 % aqueous solution,
0.34 mmol). The resulting solution was stirred for 48 h before being diluted with 
ethyl acetate (10 ml) and washed with water (3 x 1 5  ml), 0.1 M sodium thiosulfate 
(10 ml), and brine (15 ml). After drying (NagSO^) the solvent was removed under 
reduced pressure to give a yellow oil which was purified by flash silica 
chromatography [eluting with diethyl ethenhexane; (1 :1)] to yield methyl ketone 
(85) (45 mg, 48 %) as a colourless oil, Rp 0.15 [EtgO/ Hexane (1 :1)]; o^iax (neat)/ 
cm-1 3366 (m), 2978 (m), 2933 (m), 1718 (s, 0 = 0 ), 1500 (s), 1393 (s), 1368 (s), 
1167 (s), and 1054 (m); 8h (400 MHz; CZHCIg) 1.43 (9H, s, 0 0 2 0 (01+3)3), 2.12 (3H, 
s, C(O)0 Ü3), 2.90-3.24 (2H, ABX, Jab 18, ^AX 4, Jbx 4, 3-H), 4.50-4.55 (1H, m, 2-H), 
5.15 (2 H, s, COgCHaPh), 5.51 (1H, d, J11, NH) and 7.30-7.36 (5H, m, aromatic); 8c 
(125 MHz; C2HGI3) 28.10 (COgC(£H3)3), 29.71 (C(0 )&H3), 45.21 (3-0), 49.51 (2-
0 ), 67.25 (COgC.HgPh), 80.01 (COgC.(CH3)3), 128.26, 128.45 & 128.66 (Ph-C), 
135.40 (Ph ipsoC), 155.95 (NH£Ogf-Bu), 171.47 (ÜOgCHgPh) and 206.13 (0 = 0 ).
lodom ethyl ketone (91); 8 h  (200 MHz; C^HCIs) 1.45 (9H, s, COgC(CH3)3), 2.90- 
3.24 (2H, ABX, Jab 18, Jax 4, Jbx 4, 3-H), 3.78 (2H, s, CHgl), 4.50-4.55 (1H, m, 2-
H), 5.15 (2H, s, COaCHgPh), 5.43 (1H, d, J 11 , NH) and 7.30-7.36 (5H, m, 
aromatic); m/z (El) 391 { [ M - C4H8]+, 10 %), 312 (50, [M - C0 2 CHgPh]+), 91 (90, 
PhCHa+) and 57 (100, <Bu+); m/z (Cl) 465 ([/W+ NH4]+, 30 %), 448 (10, [M +  H]+),
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409 (100, [ M-  C4H8 + NH4]+).
Benzylacetone (93).
CH
To TMS-diazomethane (4 ml of a 2 M solution in hexane, 7 mmoi) at 0 °G was 
added slowly a solution of hydrocinnamic acid chloride (92) (0.5 ml, 3.4 mmol) in 
diethyl ether (5 ml). The solution was allowed to stir for 2 h before the careful and 
slow addition of 98% HI (1.5 ml). The resulting mixture was allowed to stir for a 
further 2 h before being diluted with ethyl acetate (20 ml) and washed with 0.1 M 
sodium thiosulfate (2 x 20 ml), water (20 ml), brine (20 ml) and dried (Na2S 0 4 ). 
Removal of the solvent under reduced pressure resulted in a yellow oil which was 
purified by flash silica chromatography [eluting with diethyl ethenhexane; (1 :4)] to 
yield benzylacetone (93) as a colourless oil (237 mg, 47 %); m /z  (Found: 
148.0879. C 10H 12O requires 148.0888); Ôh (270 MHz; C^HCIs) 2.15 (3H, s, 
C(0 )CH3), 2.75-2.95 (4H, m, PhCHsCHa), and 7.10-7.35 (5H, m, aromatics); m/z 
(El) 148 (M+, 70%), 133 (22, [M -  Me]+), 105 (95, [M - CH3C0 ]+), 91 (87, C7H7+) 
and 43 (100, CH3CO+).
130
Purification of threonine svnthase from E. coli Tir 8.
Buffer A: Buffer B:
50 mM HEPES 20 mM KPO4H3
1 mM DTT 1 mM DTT
2 mM EDTA 2 mM EDTA
0.25 mM PLP 0.25 mM PLP
2 mM (2S)-threonine
both adjusted to pH 7.5 with KOH solution.
1) E. coli strain Tir 8 was grown in 41 L-Broth^^^ incubating for 16 h to allow 
harvest in late log phase.
2) The cells were harvested by centrifugation at 8,000 rpm for 20 min at 4 °C, to 
yield 37 g of wet cell paste. The cell paste was resuspended in buffer (40 ml) and 
sonicated at <6 °C, for 15 min in bursts of 2 min using an Ultrasonic W-220F  
sonicator (150 W). The lysed cell debris was removed by centrifugation at 18,000 
rpm for 20 min. The resultant precipitate was discarded, and the supernatant was 
used immeadiately in the next step.
3) Streptomycin sulfate was added to the sonic extract to a final concentration of 
3% w/v, and stirred for 30 min. The precipitated nucleic acids were spun out at
18,000 rpm for 30 min and discarded.
4) The streptomycin sulfate extract (45 ml) was brought to 40% ammonium sulfate 
saturation by addition of 10.94 g precrushed ammonium sulfate in portions over 30 
min at 4 °C. The suspension was allowed to stir at 0 °C for a further 30 min before
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spinning down the precipitated proteins at 18,000 rpm for 30 min and discarding 
the precipitate.
5) The 40 % supernatant was adjusted to 60 % ammonium sulfate saturation by 
addition of a further 6.34 g of ammonium sulfate over a 20 minute period. After 
stirring this suspension for 30 min the precipitated protein was spun down at
18,000 rpm for 30 min and the supernatant discarded. The protein pellet (3.69 g) 
was resuspended in buffer A to a final volume of 7 ml (50 mg/ml). This solution was 
spun at 18,000 rpm for 30 min to remove any debris before the next purification 
step.
6) The protein solution was loaded onto a Sephadex G150 column (80 x 3 cm) 
which had been pre-equilibrated with buffer A. The column was eluted at a flow 
rate of 30 ml/h collecting 50 x 15 ml fractions. Each fraction was assayed for SAM 
enhanced phosphatase activity, and the fractions containing threonine synthase 
were pooled, and their volume reduced to approx. 3 ml by ultrafiltration, (52 mg/ 
ml).
7) The cloudy concentrated solution from the previous step was centrifuged 
(18,000 rpm, 10 min). A portion of the protein solution (0.25 ml) was diluted to 1 ml 
with H2O, and the solution applied to a DEAE Sephacel column (10 cm x 1.5 cm) 
pre-equilbrated with buffer B. The protein was eluted with a linear gradient of 0 - 
250 mM KCI in the same buffer at a flow rate of 1 ml/min, and fractions (2 ml) were 
collected. The fractions were pooled by peak, relating to the absorbance at 280 
nm. This yielded 5 fractions (Figure 2.14) each of which were reduced to approx. 
1 ml by ultrafiltration.
8 ) The fractions collected were all subjected to a G 25 column (10 cm x 2.5 cm) 
pre-equilibrated with buffer A. The column was eluted with buffer A at a flow rate of
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30 ml/ h and fractions (15 min) collected. All protein containing fractions were 
pooled and ultrafiltrated to approximately 1 ml (2 mg/ ml).
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Colourimetric Assays, 
Reagent.
Colourimetric assay reagent: Malachite green (1.5 g) was dissolved in hydrochloric 
acid (25 ml, 5 M), and diluted with water (750 ml). To this solution was added 
ammonium molybdate (10.5 g) in hydrochloric acid (225 ml, 5 M), and the solution 
stirred at room temperature for 10 minutes. The solution was filtered by gravity, and 
stored in the dark for periods of up to one month.
Threonine synthase assay.
The following crude assay was used to assess the progress of the purification of 
threonine synthase. Each vial contained 500 pi of solution, and a concentration of 
1 mM (2S)-0-phosphohomoserine at pH 7.5 in buffer A. The reaction was initiated 
started by addition of 10 pi enzyme. The assay samples were incubated at 37 °C 
for a suitable period of time, and the reaction quenched by addition to the 
malachite reagent (0.1 ml aliquot was added to 0.9 ml colorimetric assay reagent). 
The colour was allowed to develop for 20 min, and the optical adsorption at 660 nm 
was measured. Comparison of the optical adsorption between the sample, a blank 
and a sample containing 0.4 mM SAM allowed threonine synthase activity to be 
assessed.
Determination of Km and Vmax for threonine synthase.
Several solutions of (2S)-0-phosphohomoserine (20 - 500 pM) in buffer A (990 pi) 
were prepared. Enzyme (0.5 mg from G150 step) was added to each solution, and
134
aliquots (100 pi) were taken every minute over a period of 9 min. Malachite 
reagent (900 pi) was added to each aliquot immeadiately to quench the reaction, 
and the colour was allowed to develop for 20 min. The optical adsorption at 
660 nm was measured as described above. Known concentrations of phosphate 
were made up in buffer A and were assayed in the same way, to give a standard 
phosphate concentration curve (Figure 3.1) from which accurate concentrations of 
phosphate could be calculated. The entire experiment was carried out in triplicate.
Détermination of Km and Vmax for threonine synthase activated by 
SAM.
Experiments similar to those described above were performed in buffer A 
containing SAM (0.4 mM). A blank was also prepared containing enzyme (0.5 mg) 
in buffer A containing SAM (0.4 mM) to a final volume of 1 ml. The solutions were 
assayed as described above.
Determination of Km and V m a x  for the action of threonine synthase on 
(2S,3/7)-[3-2Hi]-0-phosphohomoserine.
Experiments similar to those described above for (2S)-0-phosphohom oserine  
were performed in buffer A, but using (2S,3R)-[3-2Hi]-0-phosphohomoserine as 
substrate. A blank was also prepared containing enzyme (0.5 mg) in buffer A to a 
final volume of 1 ml. The solutions were assayed as described above.
135
Determination of Km and V m a x  for the action of threonine synthase on 
(2S,3S)-[3-2Hi]“0-phosphohomoserine.
Experiments similar to those described above for (2S)-0-phosphohom oserine  
were performed in buffer A, but using (2S,3S)-[3-2Hi]-0-phosphohomoserine as 
substrate. A blank was also prepared containing enzyme (0.5 mg) in buffer A to a 
final volume of 1 ml. The solutions were assayed as described above.
Determination of Km and Vmax for the action of threonine synthase on 
(25)-[2-2Hi]-0-phosphohomoserine.
Experiments similar to those described above for (2S)-0-phosphohom oserine  
were performed in buffer A, but using (2S)-[2-2Hi]-0-phosphohom oserine as 
substrate. A blank was also prepared containing enzyme (0.5 mg) in buffer A to a 
final volume of 1 ml. The solutions were assayed as described above.
0.75-
660 0.5-
0.25“
660
0 25 50 75 100 125
Pj (uM)
Figure 3.1 : Phosphate standards.
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Appendix 1: Raw data from kinetic assays.
[s] (laM) -SAM +SAM RPHS SPHS aPH S
600
3.611
4.167
4.167
6.833
6.500
5.500
3.222
3.900
4.070
3.0330
2.188
2.357
3.731
2.883
3.333
200
3.625
3.472
2.580
4.833 
4.330
3.833
3.391
3.900
2.459
2.289
2.120
1.950
3.222
3.307
2.713
100
3.167
2.580
2.667
3.083
2.917
2.833
2.544
2.628
2.205
2.035
1.696
1.781
2.289
2.459
2.374
50
2.667  
2.417
1.667
2.500
2.167
2.750
2.035
2.289
1.865
1.583
1.865
1.696
2.205
2.035
1.781
30
1.750
1.667
1.333
2,167
2.083
1.677
1.696
1.442
1.102
1.526
1.696
1.696
1.441
1.611
20
1.667
1.667
1.250 
2.083
1.250
1.017
1.187
1.336
1.357
1.526
1.272
1.441
1.441 
1.357
Values given are iimoles phosphate formed per minute.
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Appendix 2: Purification of p-methyi aspartase from Clostridium 
tetanomorphum.
Clostridium tetanomorphum strain H1 (ATCC 15920) (obtained from the American 
Type Culture Collection) was grown according to the method of B a r k e r  ^06 using a 
modification of literature procedures, by Prof. C. Greenwood and Mr. A Thompson, 
University of East Anglia.
1) Frozen Clostridium tetanomorphum  HI cell paste (42 g) was added to 
potassium phosphate buffer (110 ml, 5 mM, pH 6 .8). After the cell paste had 
thawed, charcoal (10 g) was added and the mixture sonicated in bursts for 10 min 
at 4 °C on a power setting of 40. The cell debris was spun down at 14,000 rpm for 
50 min.
2 ) To the supernatant from above was added 12 ml of buffer (200 mM 
M g C l2 .6 H2 0 , 200 mM NH4CI and 200 mM mesaconate, pH 6 .8 ) and the 
supernatant was divided into four portions, shaken in a water bath for 10 min at 52 
°C and the debris removed by centrifugation (40 min, 18,000 rpm).
3) To the supernatant from above was slowly added 100 ml of 1% protamine 
sulphate in potassium phosphate buffer (50 mM, pH 6 .8) at 0 °C over 15 min. After 
addition, the mixture was left to stir for 15 min at 4 °C, and the debris was removed 
by centrifugation (45 min, 18,000 rpm).
4) To the supernatant from above was added potassium phosphate buffer (10 ml, 1
M, pH 7.6) followed by slow addition of ammonium sulphate to 50 % saturation at 4
°C. This was left stirring for 30 min, and the precipitated protein was removed by
centrifugation (30 min, 18,000 rpm). The supernatant was collected and
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ammonium suiphate was slowly added to a final saturation of 75 % and the mixture 
stirred for a further 30 min at 4 °C after addition. The supernatant was removed by 
centrifugation (30 min, 18,000 rpm).
5) The precipitate from above was suspended in potassium phosphate buffer (10 
ml, 50 mM, pH 7.6) and dialysed overnight against 6 I of the same buffer. The 
soiution was centrifuged (15 min, 5000 rpm) to remove any debris.
Assay of p-methyl aspartase activity.
The assay buffer consisted of Tris (0.5 M), MgCl2.6 H2 0  (2 mM), KCI (1 mM) and 3- 
methylaspartic acid (4 mM), adjusted to pH 9 with NaOH. A total volume of 3 ml 
was used and the change of absorbance at 240 nm over 1 cm was monitored. 
Typicaily the above crude preparation gave an activity of around 40 units/ml.
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